{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "735c79c3-93f0-4eac-a40a-7a9c8043a1ed",
   "metadata": {},
   "outputs": [
    {
     "name": "stdin",
     "output_type": "stream",
     "text": [
      "OPENAI_API_KEY:  ········\n"
     ]
    }
   ],
   "source": [
    "import os, getpass\n",
    "\n",
    "def _set_env(var: str):\n",
    "    if not os.environ.get(var):\n",
    "        os.environ[var] = getpass.getpass(f\"{var}: \")\n",
    "\n",
    "_set_env(\"OPENAI_API_KEY\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "789b31dd-a34b-48bc-8009-2af26b9d8803",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_openai import ChatOpenAI\n",
    "llm = ChatOpenAI(model=\"gpt-5\", temperature=0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "3696e0bc-02a8-42f7-b293-f543745fd8d7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdin",
     "output_type": "stream",
     "text": [
      "LANGSMITH_API_KEY:  ········\n"
     ]
    }
   ],
   "source": [
    "_set_env(\"LANGSMITH_API_KEY\")\n",
    "os.environ[\"LANGSMITH_TRACING\"] = \"true\"\n",
    "os.environ[\"LANGSMITH_PROJECT\"] = \"langchain-academy\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "c02b37ca-37ee-4937-a83f-28b480ef09bd",
   "metadata": {},
   "outputs": [],
   "source": [
    "from typing import List\n",
    "from typing_extensions import TypedDict\n",
    "from pydantic import BaseModel, Field\n",
    "\n",
    "class Doctor(BaseModel):\n",
    "    name: str = Field(\n",
    "        description=\"Name of the doctor.\"\n",
    "    )\n",
    "    qualifications: str = Field(\n",
    "        description=\"Qualifications of the doctor\",\n",
    "    )\n",
    "    specialization: str = Field(\n",
    "        description=\"Specialization of the dcotor i.e., cardiologist, dermatologist, orthopedist, etc.\",\n",
    "    )\n",
    "    experience: int = Field(\n",
    "        description=\"Number of years of work experience of the doctor\"\n",
    "    )\n",
    "    description: str = Field(\n",
    "        description=\"Description of the doctor's place of work, achievements, etc.\",\n",
    "    )\n",
    "    @property\n",
    "    def persona(self) -> str:\n",
    "        return f\"Name: {self.name}\\nQualifications: {self.qualifications}\\nSpecialization: {self.specialization}\\nExperience: {self.experience}\\nDescription: {self.description}\\n\"\n",
    "\n",
    "class Perspectives(BaseModel):\n",
    "    doctors: List[Doctor] = Field(\n",
    "        description=\"Comprehensive list of doctors with their specializations, place of work and qualifications.\",\n",
    "    )\n",
    "\n",
    "class GenerateDoctorsState(TypedDict):\n",
    "    symptom: str \n",
    "    max_doctors: int \n",
    "    human_feedback: str \n",
    "    doctors: List[Doctor]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "38d791e7-f23e-40ac-80b8-4bac7a4cc934",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from IPython.display import Image, display\n",
    "from langgraph.graph import START, END, StateGraph\n",
    "from langgraph.checkpoint.memory import MemorySaver\n",
    "from langchain_core.messages import AIMessage, HumanMessage, SystemMessage\n",
    "\n",
    "doctor_instructions=\"\"\"You are tasked with creating a set of Doctors. Follow these instructions carefully:\n",
    "\n",
    "1. First, take a look at the symptom: {symptom}\n",
    "        \n",
    "2. Examine any feedback that has been optionally provided to guide creation of the doctor personas: \n",
    "        \n",
    "{human_feedback}\n",
    "    \n",
    "3. Determine the most suitable specialists who can diagnose the symptom {symptom}.\n",
    "                    \n",
    "4. Pick the top {max_doctors} specialists most suited for the symptom {symptom}.\n",
    "\n",
    "5. Assign one doctor for each specialization.\"\"\"\n",
    "\n",
    "def create_doctors(state: GenerateDoctorsState):\n",
    "    \n",
    "    \"\"\" Create doctors \"\"\"\n",
    "    \n",
    "    symptom=state['symptom']\n",
    "    max_doctors=state['max_doctors']\n",
    "    human_feedback=state.get('human_feedback', '')\n",
    "        \n",
    "    structured_llm = llm.with_structured_output(Perspectives)\n",
    "\n",
    "    system_message = doctor_instructions.format(symptom=symptom,\n",
    "                                                            human_feedback=human_feedback, \n",
    "                                                            max_doctors=max_doctors)\n",
    " \n",
    "    doctors = structured_llm.invoke([SystemMessage(content=system_message)]+[HumanMessage(content=\"Generate the list of doctors.\")])\n",
    "\n",
    "\n",
    "    return {\"doctors\": doctors.doctors}\n",
    "\n",
    "def human_feedback(state: GenerateDoctorsState):\n",
    "    \"\"\" No-op node that should be interrupted on \"\"\"\n",
    "    pass\n",
    "\n",
    "\n",
    "\n",
    "def should_continue(state):\n",
    "    messages = state.get(\"messages\", [])\n",
    "    if not messages:\n",
    "        # No messages yet, decide default behavior\n",
    "        return END  # or \"create_doctors\" if you want to loop\n",
    "    last_message = messages[-1].get(\"content\", \"\").lower()\n",
    "    if \"thank you\" in last_message:\n",
    "        return END\n",
    "    elif len(messages) >= state.get(\"max_num_turns\", 15):\n",
    "        return END\n",
    "    else:\n",
    "        return \"create_doctors\"\n",
    " \n",
    "builder = StateGraph(GenerateDoctorsState)\n",
    "builder.add_node(\"create_doctors\", create_doctors)\n",
    "builder.add_node(\"human_feedback\", human_feedback)\n",
    "builder.add_edge(START, \"create_doctors\")\n",
    "builder.add_edge(\"create_doctors\", \"human_feedback\")\n",
    "builder.add_conditional_edges(\"human_feedback\", should_continue, [\"create_doctors\", END])\n",
    "\n",
    "memory = MemorySaver()\n",
    "graph = builder.compile(interrupt_before=['human_feedback'], checkpointer=memory)\n",
    "\n",
    "display(Image(graph.get_graph(xray=1).draw_mermaid_png()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "e034fe84-cd77-465f-b18e-960a9e471e07",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Dr. Aisha Rahman\n",
      "Experience(in years): 16\n",
      "Qualification: MD, FCCP (Pulmonary & Critical Care Medicine)\n",
      "Specialization: Pulmonologist\n",
      "Description: Board-certified pulmonologist at River Valley Medical Center focusing on pleuritic chest pain, pulmonary embolism, pneumonia, and asthma/COPD. Leads a multidisciplinary chest clinic and has authored peer-reviewed research on chest pain evaluation and lung imaging pathways.\n",
      "--------------------------------------------------\n",
      "Name: Dr. Miguel Alvarez\n",
      "Experience(in years): 14\n",
      "Qualification: MD, FACEP\n",
      "Specialization: Emergency Medicine Physician\n",
      "Description: Attending emergency physician at Metro City Medical Center. Specializes in rapid assessment of acute chest and lung pain, including pneumothorax, pulmonary embolism, and rib/thoracic injuries. Expert in bedside ultrasound and evidence-based chest pain/shortness-of-breath protocols.\n",
      "--------------------------------------------------\n",
      "Name: Dr. Priya Desai\n",
      "Experience(in years): 18\n",
      "Qualification: MD, FACC\n",
      "Specialization: Cardiologist\n",
      "Description: Board-certified cardiologist at Lakeside Heart Institute with expertise in differentiating cardiac from pleuritic chest pain, including ischemia and pericarditis. Oversees a chest pain unit and collaborates closely with pulmonology for comprehensive diagnostic workups.\n",
      "--------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "# Creating a list of doctors\n",
    "max_doctors = 3 \n",
    "symptom = \"I am having a pain in my lungs\"\n",
    "thread = {\"configurable\": {\"thread_id\": \"1\"}}\n",
    "doctors=()\n",
    "for event in graph.stream({\"symptom\":symptom,\"max_doctors\":max_doctors,}, thread, stream_mode=\"values\"):\n",
    "    doctors = event.get('doctors', '')\n",
    "    if doctors:\n",
    "        for doctor in doctors:\n",
    "            print(f\"Name: {doctor.name}\")\n",
    "            print(f\"Experience(in years): {doctor.experience}\")\n",
    "            print(f\"Qualification: {doctor.qualifications}\")\n",
    "            print(f\"Specialization: {doctor.specialization}\")\n",
    "            print(f\"Description: {doctor.description}\")\n",
    "            print(\"-\" * 50)  "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "8a04df8c-bc52-4f64-8bd9-2f12e2660652",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "('human_feedback',)"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "state = graph.get_state(thread)\n",
    "state.next"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "32ef6792-8589-40d1-aef9-e05c335f8160",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'configurable': {'thread_id': '1',\n",
       "  'checkpoint_ns': '',\n",
       "  'checkpoint_id': '1f0cf69f-838d-6b8e-8002-7e82919cbaa3'}}"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "graph.update_state(thread, {\"human_feedback\": \n",
    "                            \"Add a Lung cancer specialist\"}, as_node=\"human_feedback\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "3dbcfbdb-e3b0-49e8-94ae-7f77119c73bb",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Dr. Aisha Rahman\n",
      "Experience(in years): 16\n",
      "Qualification: MD, FCCP (Pulmonary & Critical Care Medicine)\n",
      "Specialization: Pulmonologist\n",
      "Description: Board-certified pulmonologist at River Valley Medical Center focusing on pleuritic chest pain, pulmonary embolism, pneumonia, and asthma/COPD. Leads a multidisciplinary chest clinic and has authored peer-reviewed research on chest pain evaluation and lung imaging pathways.\n",
      "--------------------------------------------------\n",
      "Name: Dr. Miguel Alvarez\n",
      "Experience(in years): 14\n",
      "Qualification: MD, FACEP\n",
      "Specialization: Emergency Medicine Physician\n",
      "Description: Attending emergency physician at Metro City Medical Center. Specializes in rapid assessment of acute chest and lung pain, including pneumothorax, pulmonary embolism, and rib/thoracic injuries. Expert in bedside ultrasound and evidence-based chest pain/shortness-of-breath protocols.\n",
      "--------------------------------------------------\n",
      "Name: Dr. Priya Desai\n",
      "Experience(in years): 18\n",
      "Qualification: MD, FACC\n",
      "Specialization: Cardiologist\n",
      "Description: Board-certified cardiologist at Lakeside Heart Institute with expertise in differentiating cardiac from pleuritic chest pain, including ischemia and pericarditis. Oversees a chest pain unit and collaborates closely with pulmonology for comprehensive diagnostic workups.\n",
      "--------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "for event in graph.stream(None, thread, stream_mode=\"values\"):\n",
    "    doctors = event.get('doctors', '')\n",
    "    if doctors:\n",
    "        for doctor in doctors:\n",
    "            print(f\"Name: {doctor.name}\")\n",
    "            print(f\"Experience(in years): {doctor.experience}\")\n",
    "            print(f\"Qualification: {doctor.qualifications}\")\n",
    "            print(f\"Specialization: {doctor.specialization}\")\n",
    "            print(f\"Description: {doctor.description}\")\n",
    "            print(\"-\" * 50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "c47b39c8-cde0-47e0-91dd-734ac2813e75",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'configurable': {'thread_id': '1',\n",
       "  'checkpoint_ns': '',\n",
       "  'checkpoint_id': '1f0cf69f-83bf-6e58-8003-d020ea2f4b4a'}}"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "further_feedack = None\n",
    "graph.update_state(thread, {\"human_feedback\": \n",
    "                            further_feedack}, as_node=\"human_feedback\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "f814cde1-9c42-4d1b-a183-519d3b683afd",
   "metadata": {},
   "outputs": [],
   "source": [
    "for event in graph.stream(None, thread, stream_mode=\"updates\"):\n",
    "    print(\"--Node--\")\n",
    "    node_name = next(iter(event.keys()))\n",
    "    print(node_name)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "f8536527-4a40-4fd6-afe0-f862633a0608",
   "metadata": {},
   "outputs": [],
   "source": [
    "final_state = graph.get_state(thread)\n",
    "doctors = final_state.values.get('doctors')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "bfa64fbb-63e0-4833-8c3d-c2ba40a70df2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "()"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "final_state.next"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "3fa273c3-874d-47e0-b123-c5455f6ccec1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Name: Dr. Aisha Rahman\n",
      "Experience(in years): 16\n",
      "Qualification: MD, FCCP (Pulmonary & Critical Care Medicine)\n",
      "Specialization: Pulmonologist\n",
      "Description: Board-certified pulmonologist at River Valley Medical Center focusing on pleuritic chest pain, pulmonary embolism, pneumonia, and asthma/COPD. Leads a multidisciplinary chest clinic and has authored peer-reviewed research on chest pain evaluation and lung imaging pathways.\n",
      "--------------------------------------------------\n",
      "Name: Dr. Miguel Alvarez\n",
      "Experience(in years): 14\n",
      "Qualification: MD, FACEP\n",
      "Specialization: Emergency Medicine Physician\n",
      "Description: Attending emergency physician at Metro City Medical Center. Specializes in rapid assessment of acute chest and lung pain, including pneumothorax, pulmonary embolism, and rib/thoracic injuries. Expert in bedside ultrasound and evidence-based chest pain/shortness-of-breath protocols.\n",
      "--------------------------------------------------\n",
      "Name: Dr. Priya Desai\n",
      "Experience(in years): 18\n",
      "Qualification: MD, FACC\n",
      "Specialization: Cardiologist\n",
      "Description: Board-certified cardiologist at Lakeside Heart Institute with expertise in differentiating cardiac from pleuritic chest pain, including ischemia and pericarditis. Oversees a chest pain unit and collaborates closely with pulmonology for comprehensive diagnostic workups.\n",
      "--------------------------------------------------\n"
     ]
    }
   ],
   "source": [
    "for doctor in doctors:\n",
    "    print(f\"Name: {doctor.name}\")\n",
    "    print(f\"Experience(in years): {doctor.experience}\")\n",
    "    print(f\"Qualification: {doctor.qualifications}\")\n",
    "    print(f\"Specialization: {doctor.specialization}\")\n",
    "    print(f\"Description: {doctor.description}\")\n",
    "    print(\"-\" * 50) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "92103f37-9fec-495c-aedf-ddcd48dc3b71",
   "metadata": {},
   "outputs": [],
   "source": [
    "# planning on arriving at result with the help of debates between the professionals.\n",
    "import operator\n",
    "from typing import  Annotated\n",
    "from langgraph.graph import MessagesState\n",
    "\n",
    "class DebateState(MessagesState):\n",
    "    max_num_turns: int \n",
    "    context: Annotated[list, operator.add] \n",
    "    doctors: list\n",
    "    debate: str \n",
    "    sections: list \n",
    "\n",
    "class SearchQuery(BaseModel):\n",
    "    search_query: str = Field(None, description=\"Search query for retrieval.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "3ad005b3-3990-46be-8bdc-00a5959bd0f4",
   "metadata": {},
   "outputs": [],
   "source": [
    "debate_instructions = \"\"\"You are to initiate a discussion between multiple doctors to diagnose the given symptom. \n",
    "\n",
    "Your goal is to get all of them to justify their approach and try to convince the other doctors why their way is the best. Be open to all ideas and decide the best way.\n",
    "\n",
    "1. Take turns: Have a back and forth with the other specialists on how to diagnose and treat the symptom.\n",
    "        \n",
    "2. Specific: Insights that avoid generalities and include specific knowledge from each induviduals field.\n",
    "\n",
    "Here is your topic of focus and set of goals for each doctor: {goals}\n",
    "        \n",
    "Begin by introducing yourself using a name that fits your persona, and then make your case.\n",
    "\n",
    "Continue to ask questions to drill down and refine your treatment plan for the patient.\n",
    "\n",
    "You are to make judgments based on just the symptoms of the patient, if there is any uncertainty (i.e. gender, age, history), you are to provide answers for all cases to be as all-encompassing as possible\n",
    "        \n",
    "When you are satisfied with your plan, complete the debate with: \"Thank you!\"\n",
    "\n",
    "Remember to stay in character throughout your response, reflecting the persona and goals provided to you.\"\"\"\n",
    "\n",
    "def generate_discussion(state: DebateState):\n",
    "    \"\"\" Node to generate a discussion \"\"\"\n",
    "\n",
    "    doctors = state[\"doctors\"]\n",
    "    messages = state[\"messages\"]\n",
    " \n",
    "    system_message = debate_instructions.format(goals={doctor1.persona,doctor2.persona,doctor3.persona})\n",
    "    sentence = llm.invoke([SystemMessage(content=system_message)]+messages)\n",
    "        \n",
    "    return {\"messages\": [sentence]}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "bd1ff221-cf4e-429c-a6d6-e8481a34234d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# testing out a smaple debate by making a temporary graph for debate\n",
    "\n",
    "builder = StateGraph(DebateState)\n",
    "\n",
    "builder.add_node(\"debate_step\", generate_discussion)\n",
    "builder.add_edge(START, \"debate_step\")\n",
    "def should_continue(state):\n",
    "    # stop if \"Thank you!\" appears OR turns exceeded\n",
    "    last_message = state[\"messages\"][-1].content.lower()\n",
    "\n",
    "    if \"thank you\" in last_message:\n",
    "        return END\n",
    "    if len(state[\"messages\"]) >= state[\"max_num_turns\"]:\n",
    "        return END\n",
    "    return \"debate_step\"\n",
    "builder.add_conditional_edges(\n",
    "    \"debate_step\",\n",
    "    should_continue,\n",
    "    [\"debate_step\", END]\n",
    ")\n",
    "\n",
    "memory = MemorySaver()\n",
    "graph = builder.compile(interrupt_before=[], checkpointer=memory)\n",
    "\n",
    "from IPython.display import Image, display\n",
    "\n",
    "display(Image(graph.get_graph(xray=1).draw_mermaid_png()))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "206bc3e6-2903-4d46-98f7-7286033c99d4",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "----------------------------------------------\n",
      "The patient has pleuritic chest pain and cough.\n",
      "\n",
      "----------------------------------------------\n",
      "I’m Dr. Miguel Alvarez, emergency medicine. Given pleuritic chest pain plus cough, I’m thinking immediately about pneumonia, pulmonary embolism (PE), pneumothorax, viral pleuritis, and less commonly pericarditis or rib injury. My job is to stabilize, risk-stratify, and order targeted tests without delaying time-sensitive treatments.\n",
      "\n",
      "My opening move in the ED:\n",
      "- Triage red flags and vitals: SpO2, respiratory rate, heart rate, BP, fever, mental status. Any hypotension, hypoxia, or severe distress moves this to resuscitation bay.\n",
      "- At the bedside in the first 10 minutes:\n",
      "  - Continuous pulse ox, IV access, ECG within 10 minutes, portable chest X-ray.\n",
      "  - Focused lung ultrasound (LUS): look for lung sliding (pneumothorax), B-lines/consolidation (pneumonia), pleural effusion, and pleural line irregularity.\n",
      "- Parallel labs:\n",
      "  - CBC, BMP, high-sensitivity troponin (0 and 1–3 hours), lactate if ill, CRP.\n",
      "  - D-dimer only if low-to-intermediate PE probability by decision rules.\n",
      "  - Viral testing (COVID-19/flu/RSV) in season or if syndromic.\n",
      "- Early analgesia and oxygen if <94% or in distress; NSAIDs first-line if no contraindication.\n",
      "\n",
      "Questions I need answered now:\n",
      "1) How old is the patient? Sex? Pregnant? Any cancer, recent surgery/immobilization, OCPs/HRT, prior DVT/PE, leg swelling, long travel?\n",
      "2) Fever? Sputum (color), hemoptysis, pleuritic pain location, sudden vs gradual onset, dyspnea severity.\n",
      "3) Recent viral illness, TB exposure, weight loss/night sweats, immunosuppression, asthma/COPD, smoking/vaping, chest trauma or heavy coughing spells.\n",
      "4) Any positional relief (leaning forward suggests pericarditis), and does palpation reproduce pain (rib/costochondral).\n",
      "\n",
      "I want to avoid two mistakes: missing a life threat (PE, tension pneumo) and under-treating pneumonia with effusion.\n",
      "\n",
      "Dr. Aisha Rahman, Pulmonology:\n",
      "I’m Dr. Aisha Rahman. Pleuritic chest pain with cough is “pulmonary until proven otherwise.” My differential in descending likelihood:\n",
      "- Community-acquired pneumonia (CAP), including atypicals and viral pneumonia.\n",
      "- PE with pulmonary infarct (often pleuritic, may have hemoptysis, tachycardia).\n",
      "- Pneumothorax (spontaneous in tall thin smokers/vapers, or secondary in COPD/asthma; can be post-tussive).\n",
      "- Pleural effusion/pleuritis (viral, autoimmune, TB, malignancy).\n",
      "- Asthma/COPD flare with pleural strain; costochondritis from coughing.\n",
      "\n",
      "My diagnostic priorities:\n",
      "- CXR for all. If negative but strong symptoms/signs of consolidation on LUS (subpleural consolidation with dynamic air bronchograms), I’ll trust ultrasound—early CAP can hide on X-ray.\n",
      "- Bedside LUS in expert hands outperforms CXR for pneumothorax and small effusions; it’s fast and no radiation.\n",
      "- If PE is on table: use Wells or Geneva + PERC/YEARS to guide D-dimer vs straight to CTPA. Age-adjusted or YEARS thresholds reduce false positives.\n",
      "  - YEARS: if no hemoptysis, no clinical DVT, and PE not most likely, D-dimer threshold can be 1000 ng/mL FEU; otherwise 500.\n",
      "- If sizable pleural effusion on imaging (>1 cm), I favor diagnostic thoracentesis unless heart failure is obvious: send protein, LDH (Light’s criteria), pH, glucose, cell count, Gram stain/culture, cytology; ADA if TB risk.\n",
      "- Consider TB, fungal, and malignancy if subacute course, night sweats, weight loss, or recurrent effusions.\n",
      "\n",
      "Treatment specifics I’ll push for (tailored to result):\n",
      "- CAP outpatient (no comorbidities): amoxicillin 1 g TID or doxycycline 100 mg BID for 5 days (extend if unstable or slow response). If macrolide monotherapy only where pneumococcal resistance <25%.\n",
      "- CAP with comorbidities: amox/clav 875/125 mg BID plus azithromycin, or doxycycline; or monotherapy with levofloxacin 750 mg daily (reserve if needed).\n",
      "- Suspected influenza: oseltamivir if ≤48h or severe/high risk.\n",
      "- Pneumothorax: small/stable primary → O2 and observation; larger or symptomatic → aspiration or small-bore catheter. Tension signs → immediate needle decompression, then chest tube.\n",
      "- PE confirmed: anticoagulation (e.g., apixaban/rivaroxaban load, or heparin infusion if massive or renal issues). Consider systemic thrombolysis or catheter therapy if high-risk with shock.\n",
      "- Pain: NSAIDs (ibuprofen 600–800 mg q6–8h) + topical lidocaine patches for chest wall pain. Avoid suppressing cough excessively; benzonatate PRN okay.\n",
      "\n",
      "I’d like to know: any unilateral calf swelling, pleural rub on exam, egophony, asymmetric breath sounds, hyperresonance, or friction rub?\n",
      "\n",
      "Dr. Priya Desai, Cardiology:\n",
      "I’m Dr. Priya Desai. Even with pleuritic quality and cough, cardiac conditions remain on the table, chiefly acute pericarditis and, less commonly, ACS masquerading as pleuritic discomfort.\n",
      "\n",
      "Cardiac angles I don’t want us to miss:\n",
      "- Pericarditis/perimyocarditis: sharp pleuritic pain, worse supine, better leaning forward; friction rub; viral prodrome; diffuse concave ST elevations with PR depressions (and reciprocal PR elevation in aVR). Troponin may be mildly elevated if myopericarditis.\n",
      "- ACS: 5–10% of ACS can present atypically, and coexistence of cough/fever doesn’t exclude it. A 12-lead ECG at triage and serial high-sensitivity troponins are non-negotiable.\n",
      "- Heart failure with cough/effusion: look for elevated JVP, B-lines on LUS, cardiomegaly; BNP can help if dyspnea is prominent.\n",
      "\n",
      "My immediate requests:\n",
      "- ECG now; if pericarditis features, I’d order an urgent transthoracic echo to assess for effusion/tamponade.\n",
      "- Serial high-sensitivity troponins (0/1–2 hours) with a validated algorithm.\n",
      "- If pericarditis is likely: ibuprofen 600–800 mg TID or indomethacin with colchicine (0.5 mg BID if ≥70 kg; 0.5 mg daily if <70 kg) for 3 months; PPI protection; restrict exercise. Admit if high-risk features (fever >38, large effusion, troponin rise, anticoagulation use, immunosuppression, trauma).\n",
      "- Important nuance: full-dose anticoagulation (for suspected PE) could worsen pericardial bleeding if a significant effusion exists—so if ECG/echo suggest pericarditis with effusion, we must weigh risks before anticoagulating for borderline PE probability.\n",
      "\n",
      "I’d like answers on: positional nature of pain, pericardial rub, diffuse vs regional ST changes, and whether troponin is rising.\n",
      "\n",
      "Back-and-forth and persuading each other\n",
      "\n",
      "Dr. Alvarez (ED) to Dr. Desai:\n",
      "Agreed on early ECG and troponins—those happen in my first 10 minutes. In a resource-limited or crowded ED, I’ll not delay CT for high-likelihood PE while waiting for a second troponin if ECG is nonischemic and PE risk is high. But if echo hints at pericardial effusion, I will pause to clarify the anticoag risk before giving heparin.\n",
      "\n",
      "Dr. Rahman (Pulmonology) to Dr. Alvarez:\n",
      "I strongly advocate lung ultrasound alongside CXR. If we see absent lung sliding with barcode sign, we’re done—manage pneumothorax immediately without waiting for radiology. If LUS shows focal consolidation with dynamic air bronchograms, we can begin CAP therapy even with a negative CXR.\n",
      "\n",
      "Dr. Desai (Cardiology) to Dr. Rahman:\n",
      "Fair, but be careful: pleuritic pain with diffuse ST elevation/PR depression changes the management—NSAIDs plus colchicine rather than antibiotics alone. An echo takes minutes and can prevent a dangerous miss.\n",
      "\n",
      "Dr. Alvarez (ED) to both:\n",
      "So our unified ED algorithm:\n",
      "1) Stabilize and screen: vitals, pulse ox, IV, ECG, CXR, LUS, initial labs including hs-troponin.\n",
      "2) If unstable or pneumothorax suggested by LUS/CXR: treat immediately (needle decompression/chest tube).\n",
      "3) If PE possible:\n",
      "   - Use Wells or revised Geneva. If very low risk and PERC negative, stop PE workup.\n",
      "   - If low-to-intermediate: D-dimer (age-adjusted or YEARS).\n",
      "   - If positive/high risk: CTPA (or V/Q if contrast pregnancy/renal issues).\n",
      "4) Infectious track:\n",
      "   - Fever, purulent sputum, focal auscultation/LUS/CXR → treat CAP; viral swab; decide disposition by PSI/CURB-65 and oxygen needs.\n",
      "5) Cardiac track:\n",
      "   - ECG and serial troponins. If pericarditis suspected, add CRP and get TTE. Manage with NSAIDs+colchicine; consider admission if high risk.\n",
      "\n",
      "Specific branching plans by likely scenarios\n",
      "\n",
      "A) Fever, productive cough, pleuritic pain, focal crackles or LUS consolidation; stable vitals:\n",
      "- Tests: CXR, viral PCR, CBC, CRP, pulse oximetry; PE risk usually low—use PERC to avoid D-dimer if appropriate.\n",
      "- Outpatient CAP therapy:\n",
      "  - Healthy adult: amoxicillin 1 g TID or doxycycline 100 mg BID for 5 days.\n",
      "  - With comorbidities: amox/clav 875/125 mg BID plus azithromycin (500 mg day 1 then 250 mg daily) or doxycycline; or levofloxacin 750 mg daily if needed.\n",
      "- Adjuncts: NSAIDs for pleurisy, benzonatate PRN, inhaled bronchodilator if wheeze, hydration, incentive spirometry.\n",
      "- Red flags to admit: SpO2 <90–92% RA, RR >30, multilobar disease, confusion, hypotension, high PSI/CURB-65, significant comorbidities.\n",
      "\n",
      "B) Sudden sharp pleuritic pain after cough, dyspnea, unilateral decreased breath sounds/hyperresonance; LUS with absent sliding:\n",
      "- Small/stable primary pneumothorax: O2 and observation with repeat imaging in 4–6 hours.\n",
      "- Larger/symptomatic: needle aspiration or pigtail catheter with Heimlich valve; admit if secondary or unstable.\n",
      "- Tension signs: immediate needle decompression then chest tube.\n",
      "\n",
      "C) Pleuritic pain, dyspnea, tachycardia, normal CXR or wedge-shaped infarct, hemoptysis or unilateral leg swelling, moderate/high Wells:\n",
      "- Skip D-dimer and get CTPA; start anticoagulation if no high bleeding risk. If pregnant/contrast allergy → V/Q.\n",
      "- If CTPA positive: DOAC loading (e.g., apixaban 10 mg BID x7 days then 5 mg BID) if stable; heparin drip if massive PE or planned procedures. Consider echo for RV strain; thrombolysis if hypotensive/shock.\n",
      "\n",
      "D) Viral prodrome, pleuritic chest pain worse lying flat, improved leaning forward; friction rub; ECG with diffuse concave ST elevation and PR depression; troponin normal or mildly up:\n",
      "- Pericarditis: ibuprofen 600–800 mg TID for 1–2 weeks with taper guided by symptoms/CRP, colchicine 0.5 mg BID (≥70 kg) for 3 months, PPI; activity restriction. Echo to assess effusion. Admit if high-risk features or significant effusion.\n",
      "- Avoid anticoagulation unless there is an unequivocal indication.\n",
      "\n",
      "E) Subacute cough, weight loss, night sweats, unilateral exudative effusion:\n",
      "- Thoracentesis: Light’s criteria; send ADA, cytology, cultures. Consider TB, malignancy. CT chest with contrast for pleura and parenchyma.\n",
      "\n",
      "Key questions for the patient to refine our plan\n",
      "- Age, sex, pregnancy status.\n",
      "- Fever, rigors, myalgias; COVID/flu exposure.\n",
      "- Sputum character; any hemoptysis.\n",
      "- Onset and exact location of pain; trauma or heavy coughing.\n",
      "- Dyspnea severity; home pulse oximeter readings if available.\n",
      "- VTE risks: recent travel/immobility, surgery, cancer, prior clot, leg swelling, OCPs/HRT, smoking.\n",
      "- Positional relief; chest wall tenderness on palpation.\n",
      "- History: asthma/COPD, TB exposure, immunosuppression.\n",
      "\n",
      "Consensus next steps before results are known\n",
      "- Do now: ECG, CXR, LUS, pulse ox, CBC/BMP, hs-troponin, CRP; apply Wells/PERC. Start NSAID analgesia if no contraindication, oxygen if <94%.\n",
      "- Depending on probability: D-dimer or straight to CTPA for PE; viral PCR in season.\n",
      "- If clear CAP on imaging and low PE risk: start antibiotics as above.\n",
      "- If pericarditis suspected from ECG/exam: echo and start NSAID+colchicine; avoid anticoagulation unless necessary.\n",
      "- Dispo: Admit if hypoxic, hemodynamically unstable, severe PE/CAP, large effusion, or concerning comorbidities; otherwise outpatient with strict return precautions and follow-up within 24–72 hours.\n",
      "\n",
      "Please provide:\n",
      "- Vitals (HR, RR, BP, SpO2, temp)\n",
      "- Age/sex/pregnancy\n",
      "- Pain description and triggers\n",
      "- Cough details and any hemoptysis\n",
      "- Risk factors for PE or infection\n",
      "- Any exam findings you have (breath sounds, rubs, leg swelling)\n",
      "\n",
      "We’ll adjust immediately once we have that information. Thank you!\n"
     ]
    }
   ],
   "source": [
    "# Input\n",
    "doctor1=doctors[0]\n",
    "doctor2=doctors[1]\n",
    "doctor3=doctors[2]\n",
    "max_num_turns = 15\n",
    "topic = \"Treating the symptom\"\n",
    "thread = {\"configurable\": {\"thread_id\": \"2\"}}\n",
    "initial_state = {\n",
    "    \"messages\": [\n",
    "        {\"role\": \"user\", \"content\": \"The patient has pleuritic chest pain and cough.\"}\n",
    "    ],\n",
    "    \"doctors\": doctors,\n",
    "    \"context\": [],\n",
    "    \"max_num_turns\": max_num_turns,\n",
    "    \"debate\": topic,\n",
    "    \"sections\": []\n",
    "}\n",
    "\n",
    "\n",
    "for event in graph.stream(initial_state, thread, stream_mode=\"values\"):\n",
    "    if \"messages\" in event:\n",
    "        print(\"\\n----------------------------------------------\")\n",
    "        print(event[\"messages\"][-1].content)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "9e977c2e-52d8-481a-a07f-5e17071e364c",
   "metadata": {},
   "outputs": [
    {
     "name": "stdin",
     "output_type": "stream",
     "text": [
      "TAVILY_API_KEY:  ········\n"
     ]
    }
   ],
   "source": [
    "# integration of web search\n",
    "\n",
    "def _set_env(var: str):\n",
    "    if not os.environ.get(var):\n",
    "        os.environ[var] = getpass.getpass(f\"{var}: \")\n",
    "\n",
    "_set_env(\"TAVILY_API_KEY\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "41ff1bda-7315-4453-8d49-75b443f9bd80",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\hp\\AppData\\Local\\Temp\\ipykernel_20148\\3381304624.py:2: LangChainDeprecationWarning: The class `TavilySearchResults` was deprecated in LangChain 0.3.25 and will be removed in 1.0. An updated version of the class exists in the :class:`~langchain-tavily package and should be used instead. To use it run `pip install -U :class:`~langchain-tavily` and import as `from :class:`~langchain_tavily import TavilySearch``.\n",
      "  tavily_search = TavilySearchResults(max_results=3)\n"
     ]
    }
   ],
   "source": [
    "from langchain_community.tools.tavily_search import TavilySearchResults\n",
    "tavily_search = TavilySearchResults(max_results=3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "cb8b7bac-ac19-48bf-b576-f01f4998e862",
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_community.document_loaders import WikipediaLoader"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "562dcdb3-11fc-4cee-b8d7-6a189d2ab595",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from langchain_core.messages import get_buffer_string\n",
    "\n",
    "search_instructions = SystemMessage(content=f\"\"\"You will be given a conversation between medical experts diagnosing a symptom. \n",
    "\n",
    "Your goal is to generate a well-structured query for use in retrieval and / or web-search related to the conversation.\n",
    "        \n",
    "First, analyze the full conversation.\n",
    "\n",
    "Pay particular attention to the treatment plan posed by each doctor.\n",
    "\n",
    "Verify this final plan using a well-structured web search query\"\"\")\n",
    "\n",
    "def search_web(state: DebateState):\n",
    "\n",
    "    structured_llm = llm.with_structured_output(SearchQuery)\n",
    "    search_query = structured_llm.invoke([search_instructions] + state['messages'])\n",
    "\n",
    "    search_docs = tavily_search.invoke(search_query.search_query)\n",
    "\n",
    "    if isinstance(search_docs, dict) and \"results\" in search_docs:\n",
    "        search_docs = search_docs[\"results\"]\n",
    "\n",
    "    formatted = []\n",
    "\n",
    "    for doc in search_docs:\n",
    "        if isinstance(doc, dict):\n",
    "            url = doc.get(\"url\", \"unknown\")\n",
    "            content = doc.get(\"content\", str(doc))\n",
    "            formatted.append(\n",
    "                f'<Document href=\"{url}\">\\n{content}\\n</Document>'\n",
    "            )\n",
    "        else:\n",
    "            formatted.append(\n",
    "                f'<Document>\\n{str(doc)}\\n</Document>'\n",
    "            )\n",
    "\n",
    "    return {\"context\": [\"\\n\\n---\\n\\n\".join(formatted)]}\n",
    "\n",
    "\n",
    "def search_wikipedia(state: DebateState):\n",
    "    \n",
    "    \"\"\" Retrieve docs from wikipedia \"\"\"\n",
    "\n",
    "    structured_llm = llm.with_structured_output(SearchQuery)\n",
    "    search_query = structured_llm.invoke([search_instructions]+state['messages'])\n",
    "    \n",
    "    search_docs = WikipediaLoader(query=search_query.search_query, \n",
    "                                  load_max_docs=3).load()\n",
    "\n",
    "    formatted_search_docs = \"\\n\\n---\\n\\n\".join(\n",
    "        [\n",
    "            f'<Document source=\"{doc.metadata[\"source\"]}\" page=\"{doc.metadata.get(\"page\", \"\")}\"/>\\n{doc.page_content}\\n</Document>'\n",
    "            for doc in search_docs\n",
    "        ]\n",
    "    )\n",
    "\n",
    "    return {\"context\": [formatted_search_docs]} \n",
    "\n",
    "def merge_search_results(state: DebateState):\n",
    "    merged = \"\\n\\n\".join(state[\"context\"])\n",
    "    return {\"context\": [merged]}\n",
    "\n",
    "def generate_treatment_plan(state: DebateState):\n",
    "    \"\"\"\n",
    "    Node that merges:\n",
    "    - all debate conversation\n",
    "    - web + wikipedia search context\n",
    "    and generates a final, unified medical treatment plan.\n",
    "    \"\"\"\n",
    "\n",
    "    messages = state[\"messages\"]            \n",
    "    context_list = state.get(\"context\", []) \n",
    "    debate_topic = state.get(\"debate\", \"\")  \n",
    "    \n",
    "    context_text = \"\\n\\n\".join(context_list) if context_list else \"No external context available.\"\n",
    "    \n",
    "    system_message = \"\"\"You are a panel lead physician tasked with producing the *final medical treatment plan based on:\n",
    "\n",
    "    1. The entire debate between specialists.\n",
    "    2. The combined search context (clinical guidelines, web results, wikipedia summaries).\n",
    "    3. The patient’s main complaint: {debate_topic}\n",
    "\n",
    "    Your output must be:\n",
    "\n",
    "    - Structured\n",
    "    - Evidence-based\n",
    "    - Reflective of the discussion points raised by all specialists\n",
    "    - Clear and clinically actionable\n",
    "\n",
    "    DO NOT repeat the debate.\n",
    "    DO NOT repeat the search results.\n",
    "    Synthesize everything into a **single, authoritative treatment plan**.\n",
    "\n",
    "    Include:\n",
    "    - Primary diagnosis or differential\n",
    "    - Recommended diagnostic tests with justification\n",
    "    - Initial treatment\n",
    "    - Follow-up considerations\n",
    "    - Any red flags or escalation scenarios\n",
    "\n",
    "Finish with: “Final plan complete.”\n",
    "\"\"\"\n",
    "\n",
    "    final_response = llm.invoke([SystemMessage(content=system_message)] + messages)\n",
    "    final_response.name = \"treatment_plan\"\n",
    "\n",
    "    return {\"messages\": [final_response]}\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "# Add nodes and edges \n",
    "debate_builder = StateGraph(DebateState)\n",
    "debate_builder.add_node(\"debate_step\", generate_discussion)\n",
    "debate_builder.add_node(\"search_web\", search_web)\n",
    "debate_builder.add_node(\"search_wikipedia\", search_wikipedia)\n",
    "debate_builder.add_node(\"merge_search_results\", merge_search_results)\n",
    "debate_builder.add_node(\"generate_treatment_plan\", generate_treatment_plan)\n",
    "\n",
    "# Flow\n",
    "debate_builder.add_edge(START, \"debate_step\")\n",
    "debate_builder.add_edge(\"debate_step\", \"search_web\")\n",
    "debate_builder.add_edge(\"debate_step\", \"search_wikipedia\")\n",
    "debate_builder.add_edge(\"search_web\", \"merge_search_results\")\n",
    "debate_builder.add_edge(\"search_wikipedia\", \"merge_search_results\")\n",
    "debate_builder.add_edge(\"merge_search_results\", \"generate_treatment_plan\")\n",
    "debate_builder.add_edge(\"generate_treatment_plan\", END)\n",
    "\n",
    "# debate \n",
    "memory = MemorySaver()\n",
    "debate_graph = debate_builder.compile(checkpointer=memory).with_config(run_name=\"Conduct Debate\")\n",
    "\n",
    "# View\n",
    "display(Image(debate_graph.get_graph().draw_mermaid_png()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "9f6b45e0-512c-469e-bd35-493e63b4752b",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Comprehensive treatment plan for pleuritic chest pain with cough\n",
      "\n",
      "Primary diagnosis and prioritized differential\n",
      "- High-risk, must exclude early:\n",
      "  - Pulmonary embolism (PE)\n",
      "  - Pneumothorax (including tension)\n",
      "  - Community-acquired pneumonia ± parapneumonic effusion/empyema\n",
      "  - Acute pericarditis/myopericarditis\n",
      "  - Acute coronary syndrome (ACS), especially if atypical\n",
      "- Other considerations:\n",
      "  - Viral pleurisy/bronchitis\n",
      "  - Costochondritis or rib fracture\n",
      "  - Exacerbation of asthma/COPD with pleuritic pain\n",
      "  - Tuberculosis or malignancy-related pleural disease (if subacute/chronic features or risk factors)\n",
      "\n",
      "Recommended diagnostic tests with justification\n",
      "Immediate triage (perform in parallel):\n",
      "- Vitals and pulse oximetry: identify hypoxemia, tachycardia, fever, shock.\n",
      "- 12‑lead ECG within 10 minutes: screen for ACS, pericarditis patterns, and PE-related strain.\n",
      "- Chest X-ray (PA/lateral when possible): evaluate for pneumonia, effusion, pneumothorax, alternative diagnoses.\n",
      "- Point-of-care ultrasound (lung and focused cardiac) when available:\n",
      "  - Lung: pneumothorax (absent sliding), B-lines/interstitial process, effusion (and guide thoracentesis decision).\n",
      "  - Cardiac: pericardial effusion/tamponade, RV dilation/strain suggestive of PE.\n",
      "\n",
      "Laboratory tests:\n",
      "- CBC, BMP: infection, anemia, renal function (affects imaging/medication choices).\n",
      "- High-sensitivity troponin (repeat at 1–3 hours if initial nondiagnostic): ACS/myopericarditis assessment.\n",
      "- CRP/ESR: support pericarditis/infection and trend response.\n",
      "- D-dimer only if PE pretest probability is low to intermediate: use age-adjusted threshold; skip D-dimer if PE probability moderate-high and proceed to imaging.\n",
      "- Viral PCR (COVID-19/influenza) during respiratory virus season or compatible syndrome.\n",
      "- Pregnancy test if applicable.\n",
      "- Blood cultures and sputum culture/Gram stain if febrile with suspected moderate–severe pneumonia or sepsis.\n",
      "\n",
      "Decision-directed imaging:\n",
      "- Suspected PE:\n",
      "  - Use Wells or YEARS criteria. If likely or D-dimer positive, obtain CT pulmonary angiography (CTPA).\n",
      "  - If pregnancy, contrast allergy, or significant renal dysfunction: ventilation–perfusion (V/Q) scan; positive lower-extremity venous ultrasound can confirm venous thromboembolism and justify anticoagulation without chest CT.\n",
      "- Suspected pericarditis/myopericarditis: transthoracic echocardiogram same-day to assess for effusion/tamponade and LV/RV function.\n",
      "- Pleural effusion ≥10 mm or with fever/pleuritic pain: diagnostic thoracentesis (protein, LDH, glucose, pH, Gram stain/culture, cytology). pH <7.2 suggests complicated effusion/empyema needing drainage.\n",
      "\n",
      "Initial treatment (tailored once diagnosis clarified)\n",
      "Supportive and symptom control (start immediately):\n",
      "- Oxygen to maintain SpO2 ≥92% (≥88–92% in chronic hypercapnia/COPD).\n",
      "- Analgesia: acetaminophen first-line. Avoid NSAIDs until MI reasonably excluded; then use as indicated below. Consider low-dose opioids short term only if pain uncontrolled and life-threatening causes excluded.\n",
      "\n",
      "If community-acquired pneumonia:\n",
      "- Outpatient, no comorbidities: amoxicillin 1 g PO TID or doxycycline 100 mg PO BID for 5 days minimum (extend until afebrile and clinically stable for 48–72 hours). A macrolide only if local pneumococcal resistance <25%.\n",
      "- Outpatient, with comorbidities (chronic heart/lung/liver/renal disease, diabetes, alcoholism, malignancy, asplenia): amoxicillin-clavulanate 875/125 mg PO BID plus doxycycline or azithromycin; or monotherapy with a respiratory fluoroquinolone (e.g., levofloxacin 750 mg daily) if alternatives unsuitable.\n",
      "- Inpatient/severe: ceftriaxone IV plus azithromycin IV, or levofloxacin IV; follow sepsis protocols if indicated.\n",
      "- Add inhaled bronchodilator if wheezing; consider benzonatate or dextromethorphan for cough once red flags excluded.\n",
      "\n",
      "If pulmonary embolism:\n",
      "- If clinical probability high and imaging delayed with low bleeding risk: start anticoagulation empirically.\n",
      "- Direct oral anticoagulant options:\n",
      "  - Apixaban: 10 mg PO BID for 7 days, then 5 mg PO BID.\n",
      "  - Rivaroxaban: 15 mg PO BID for 21 days, then 20 mg PO daily.\n",
      "- Use LMWH in pregnancy or if DOACs contraindicated; adjust for renal impairment.\n",
      "- Risk stratify (e.g., sPESI). Outpatient treatment only if low-risk, hemodynamically stable, no RV strain, reliable follow-up. Massive/high-risk PE with hypotension/shock: immediate thrombolysis or thrombectomy per local protocol.\n",
      "\n",
      "If acute pericarditis (after ruling out MI):\n",
      "- NSAID: ibuprofen 600–800 mg PO TID (or high-dose aspirin 650–1,000 mg TID) with slow taper over 2–4 weeks guided by symptoms/CRP.\n",
      "- Colchicine: 0.5 mg PO BID (>70 kg) or 0.5 mg daily (<70 kg) for 3 months.\n",
      "- PPI for gastroprotection while on NSAIDs.\n",
      "- Activity restriction: avoid strenuous exercise until symptom-free and inflammatory markers normalized.\n",
      "- Admit if any high-risk feature: fever >38°C, subacute onset, large effusion, tamponade, immunosuppression, oral anticoagulation/bleeding risk, elevated troponin (myopericarditis), or refractory pain.\n",
      "\n",
      "If pneumothorax:\n",
      "- Small, primary, minimally symptomatic: observe with supplemental oxygen and repeat imaging.\n",
      "- Large/symptomatic or secondary (e.g., COPD): needle aspiration or small-bore chest tube; admit. Tension pneumothorax: immediate needle decompression followed by chest tube.\n",
      "\n",
      "If ACS suspected (ischemic ECG changes or dynamic troponin rise):\n",
      "- Manage per ACS protocol: aspirin loading dose, anticoagulation (heparin), anti-ischemic therapy, and cardiology consultation for early invasive evaluation. Avoid NSAIDs.\n",
      "\n",
      "If asthma/COPD exacerbation:\n",
      "- Nebulized albuterol ± ipratropium; systemic corticosteroids (e.g., prednisone 40 mg daily for 5 days in COPD; 5–7 days in asthma); evaluate for concomitant pneumonia/PE.\n",
      "\n",
      "Special populations/considerations\n",
      "- Pregnancy: favor V/Q scan for PE; treat PE with LMWH; avoid doxycycline and fluoroquinolones; for pneumonia use amoxicillin/amoxicillin-clavulanate ± azithromycin.\n",
      "- Renal impairment: adjust contrast decisions and DOAC dosing.\n",
      "- Anticoagulation/bleeding risk: weigh thoracentesis and NSAID use carefully.\n",
      "\n",
      "Follow-up and monitoring\n",
      "- If discharged:\n",
      "  - Reassessment within 24–72 hours, sooner if symptoms progress.\n",
      "  - Pneumonia: confirm symptom improvement at 48–72 hours; consider repeat chest X-ray in 6 weeks for patients ≥50, smokers, or with lobar consolidation to exclude obstructing lesion.\n",
      "  - Pericarditis: clinic review in 1 week to assess pain, exam, and CRP; reinforce NSAID taper and colchicine adherence; educate on activity restriction.\n",
      "  - PE: arrange anticoagulation follow-up within 1 week; educate on bleeding precautions; plan minimum 3 months of therapy, longer if unprovoked with persistent risk factors—consider thrombophilia testing and cancer screening when appropriate.\n",
      "  - Pneumothorax: repeat imaging in 24–48 hours; counsel to avoid air travel/scuba until radiographic resolution; smoking cessation support.\n",
      "\n",
      "Red flags or escalation scenarios (seek emergency care immediately)\n",
      "- Severe or worsening shortness of breath; SpO2 <92% at rest (or <90% at altitude) despite rest.\n",
      "- Syncope, presyncope, new confusion, or hypotension.\n",
      "- Hemoptysis, one-sided leg swelling/pain, or sudden pleuritic chest pain after immobilization/surgery/long travel.\n",
      "- Signs of pericardial tamponade: hypotension, distended neck veins, muffled heart sounds, pulsus paradoxus.\n",
      "- Evidence of large/tension pneumothorax: severe unilateral pleuritic pain with acute dyspnea, tracheal deviation, hemodynamic instability.\n",
      "- Persistent fever >38.5°C beyond 48–72 hours of antibiotics, or rigors.\n",
      "- Uncontrolled chest pain or rapidly worsening symptoms.\n",
      "- Pregnancy/postpartum with chest pain or dyspnea.\n",
      "\n",
      "Patient education and safety\n",
      "- Avoid strenuous activity until diagnosis clarified and symptoms controlled.\n",
      "- Hydration, incentive spirometry for pleuritic splinting if pneumonia suspected.\n",
      "- Vaccinations: influenza and COVID-19 if not current; pneumococcal vaccination per age/comorbidity.\n",
      "- Smoking cessation support if applicable.\n",
      "\n",
      "This plan prioritizes rapid exclusion of life-threatening causes while providing diagnosis-specific pathways and treatments. Adjust antibiotic and anticoagulant choices for allergies, drug interactions, renal/hepatic function, and pregnancy status.\n",
      "\n",
      "Final plan complete.\n"
     ]
    }
   ],
   "source": [
    "# Input\n",
    "doctor1=doctors[0]\n",
    "doctor2=doctors[1]\n",
    "doctor3=doctors[2]\n",
    "max_num_turns = 15\n",
    "topic = \"Treating the symptom\"\n",
    "thread = {\"configurable\": {\"thread_id\": \"2\"}}\n",
    "initial_state = {\n",
    "    \"messages\": [\n",
    "        {\"role\": \"user\", \"content\": \"The patient has pleuritic chest pain and cough.\"}\n",
    "    ],\n",
    "    \"doctors\": doctors,\n",
    "    \"context\": [],\n",
    "    \"max_num_turns\": max_num_turns,\n",
    "    \"debate\": topic,\n",
    "    \"sections\": []\n",
    "}\n",
    "\n",
    "\n",
    "final_plan = None\n",
    "\n",
    "for event in debate_graph.stream(initial_state, thread, stream_mode=\"values\"):\n",
    "    if \"messages\" in event:\n",
    "        msg = event[\"messages\"][-1]\n",
    "\n",
    "        if getattr(msg, \"name\", None) == \"treatment_plan\":\n",
    "            final_plan = msg.content\n",
    "\n",
    "# Print only the final treatment plan\n",
    "print(final_plan)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "33d2a5e3-8a52-412e-82cd-5ef35e3e57d2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from dataclasses import dataclass, field\n",
    "@dataclass\n",
    "class FinalState:\n",
    "    symptom: str \n",
    "    max_doctors: int  \n",
    "    doctors: List[Doctor]\n",
    "    max_num_turns: int \n",
    "    context: Annotated[list, operator.add] \n",
    "    debate: str \n",
    "    sections: list\n",
    "    \n",
    "\n",
    "def bridge(FinalState):\n",
    "    return FinalState\n",
    "\n",
    "full_builder = StateGraph(FinalState)\n",
    "full_builder.add_node(\"create_doctors\", create_doctors)\n",
    "#full_builder.add_node(\"human_feedback\", human_feedback)\n",
    "\n",
    "full_builder.add_node(\"bridge\",bridge)\n",
    "\n",
    "full_builder.add_node(\"debate_step\", generate_discussion)\n",
    "full_builder.add_node(\"search_web\", search_web)\n",
    "full_builder.add_node(\"search_wikipedia\", search_wikipedia)\n",
    "full_builder.add_node(\"merge_search_results\", merge_search_results)\n",
    "full_builder.add_node(\"generate_treatment_plan\", generate_treatment_plan)\n",
    "\n",
    "# Flow\n",
    "full_builder.add_edge(START, \"create_doctors\")\n",
    "full_builder.add_edge(\"create_doctors\", \"bridge\")\n",
    "#full_builder.add_conditional_edges(\"human_feedback\", should_continue, [\"create_doctors\", \"bridge\"])\n",
    "\n",
    "\n",
    "\n",
    "full_builder.add_edge(\"bridge\", \"debate_step\")\n",
    "full_builder.add_edge(\"debate_step\", \"search_web\")\n",
    "full_builder.add_edge(\"debate_step\", \"search_wikipedia\")\n",
    "full_builder.add_edge(\"search_web\", \"merge_search_results\")\n",
    "full_builder.add_edge(\"search_wikipedia\", \"merge_search_results\")\n",
    "full_builder.add_edge(\"merge_search_results\", \"generate_treatment_plan\")\n",
    "full_builder.add_edge(\"generate_treatment_plan\", END)\n",
    "\n",
    "# debate \n",
    "memory = MemorySaver()\n",
    "final_graph = full_builder.compile(checkpointer=memory).with_config(run_name=\"Full run\")\n",
    "\n",
    "# View\n",
    "display(Image(final_graph.get_graph().draw_mermaid_png()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "5d808d56-a7e3-4d51-8f31-522b4206e700",
   "metadata": {},
   "outputs": [
    {
     "name": "stdin",
     "output_type": "stream",
     "text": [
      "Enter symptom I have head ache\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "dict_keys(['symptom', 'max_doctors', 'doctors', 'max_num_turns', 'context', 'debate', 'sections', 'messages'])\n",
      "[Doctor(name='Dr. Anika Mehra, MD, FAAN', qualifications='MD (Neurology), Fellowship in Headache Medicine, FAAN', specialization='Neurologist', experience=15, description='Senior neurologist at City Neurology & Headache Center leading a multidisciplinary headache clinic. Expertise in migraine, cluster headache, and secondary headache evaluation; offers CGRP therapies, onabotulinumtoxinA for chronic migraine, and nerve blocks. Published in Cephalalgia and active member of the American Headache Society.'), Doctor(name='Dr. Samuel Ortiz, MD', qualifications='MD, Board Certified in Internal Medicine', specialization='Internal Medicine (Primary Care)', experience=12, description='Primary care physician at Downtown Internal Medicine Associates focusing on first-line headache assessment. Screens for red flags, manages tension-type headaches, coordinates imaging when indicated, and provides lifestyle counseling and medication-overuse prevention. Leads clinic quality initiatives for evidence-based headache pathways.'), Doctor(name='Dr. Leila Haddad, MD, FRCOphth', qualifications='MD, FRCOphth, Fellowship in Neuro-Ophthalmology', specialization='Ophthalmologist', experience=13, description='Consultant ophthalmologist at Vision & Eye Strain Clinic with subspecialty in neuro-ophthalmology. Evaluates headaches related to eye strain, refractive error, glaucoma, optic neuritis, and idiopathic intracranial hypertension; performs comprehensive eye exams, OCT, and visual field testing, and collaborates closely with neurology for complex cases.')]\n",
      "Dr. Miguel Alvarez (Emergency Medicine): I’m Dr. Miguel Alvarez, emergency physician. If the presenting symptom is sharp, pleuritic chest pain (worse with deep breath/cough), my priority is ruling out immediately life-threatening causes within minutes: pulmonary embolism (PE), pneumothorax, pericarditis with tamponade, and less likely but critical aortic dissection and acute coronary syndrome (ACS). My first moves in the ED:\n",
      "- Triage and monitoring: vitals, continuous pulse ox, 12‑lead ECG within 10 minutes, IV access.\n",
      "- Focused bedside lung and cardiac ultrasound: look for absent lung sliding/“barcode” sign (pneumothorax), pleural effusion, focal consolidation with dynamic air bronchograms (pneumonia), RV strain or pericardial effusion/tamponade physiology.\n",
      "- Immediate analgesia and oxygen if SpO2 < 94%.\n",
      "\n",
      "Questions for the patient:\n",
      "- Onset and character: sudden vs gradual? Worsened by inspiration, cough, or lying flat? Better leaning forward?\n",
      "- Dyspnea severity, syncope, hemoptysis, fever/cough/sputum, calf pain/swelling, recent immobilization/surgery/long flight, known cancer, prior DVT/PE.\n",
      "- Trauma (even minor), body habitus (tall/slender or COPD risk for pneumothorax), recent viral illness.\n",
      "- Risk factors: pregnancy, OCPs/HRT, smoking, cocaine.\n",
      "- Chest wall tenderness, dermatomal rash (zoster), autoimmune disease.\n",
      "- For ACS overlap: exertional chest pressure, radiation to arm/jaw, diaphoresis, N/V.\n",
      "\n",
      "Based on answers and vitals, I’ll apply:\n",
      "- PE: PERC (if pretest probability truly low); if not low, use Wells/YEARS to guide D‑dimer and imaging. Age‑adjust D‑dimer: age × 10 ng/mL (FEU) if >50. YEARS: if 0 items and D‑dimer <1000 FEU, PE excluded; if ≥1 item, threshold 500.\n",
      "- Pneumothorax: if unstable with absent breath sounds and hypotension/JVD, decompress immediately; otherwise confirm with lung US/CXR.\n",
      "- Pericarditis: pleuritic pain worse supine, better leaning forward; pericardial rub; ECG with diffuse ST elevations and PR depression. Echo for effusion.\n",
      "- ACS: even if pleuritic, I won’t ignore ischemia—serial high‑sensitivity troponins at 0/1–2 hours with HEART score.\n",
      "\n",
      "Dr. Aisha Rahman (Pulmonology): I’m Dr. Aisha Rahman, pulmonologist. My lens is that pleuritic pain is pulmonary until proven otherwise. Over-testing is a risk, but missing PE or pneumothorax is worse. I advocate a structured pretest pathway to avoid unnecessary CTPA:\n",
      "- If vitals normal, SpO2 ≥ 96%, no risk factors, PERC negative, and normal lung US/CXR: likely benign/viral pleurisy or costochondritis—no D‑dimer or CT needed. NSAIDs and follow‑up.\n",
      "- If PE is possible (Wells ≥ 2 or YEARS positive), get D‑dimer with appropriate thresholding; proceed to CTPA if positive. Special cases:\n",
      "  - Pregnancy: obtain CXR first; if normal, V/Q scan preferred; if abnormal CXR or V/Q unavailable, CTPA with pregnancy protocol shielding. Use clinical gestalt—don’t use D‑dimer late pregnancy.\n",
      "  - Renal dysfunction or severe contrast allergy: consider V/Q or lower‑extremity Doppler ultrasound; treat if proximal DVT found.\n",
      "- Imaging specifics:\n",
      "  - Lung US: pneumothorax—absence of lung sliding, lung point if present is pathognomonic; pneumonia—subpleural consolidation, B‑lines, dynamic air bronchograms; pleural effusion—anechoic dependent fluid.\n",
      "  - CXR: quick screen for pneumothorax (expiratory film not needed with US), lobar pneumonia, effusion, rib fractures.\n",
      "- If pneumonia suspected: obtain CXR and consider procalcitonin if equivocal; risk stratify with CURB‑65 or PSI for disposition. Treat per guideline (e.g., outpatient amoxicillin/clavulanate + doxycycline or a respiratory fluoroquinolone in select cases; inpatient ceftriaxone + azithromycin).\n",
      "- If isolated pleuritis (viral/autoimmune): NSAIDs (e.g., ibuprofen 600–800 mg TID with PPI), consider colchicine 0.5 mg BID for 1–2 weeks for recurrent pleurisy; check CRP/ESR. If recurrent/prolonged or with exudative effusion, evaluate for TB, malignancy, autoimmune disease.\n",
      "\n",
      "Dr. Priya Desai (Cardiology): I’m Dr. Priya Desai, cardiologist. Pleuritic pain is often non-ischemic, but I’m most concerned about pericarditis, myocarditis, PE‑related RV strain, and the rare ACS that presents atypically. My concrete steps:\n",
      "- ECG interpretation specifics:\n",
      "  - Acute pericarditis: diffuse concave ST elevation with PR depression; Spodick’s sign (downsloping TP segment). No reciprocal ST depression except aVR/V1.\n",
      "  - PE: sinus tachycardia; S1Q3T3, T‑wave inversions V1–V4, right axis, incomplete RBBB—suggestive of RV strain.\n",
      "  - ACS: localized ST changes, reciprocal depressions.\n",
      "- Biomarkers:\n",
      "  - High‑sensitivity troponin 0/1‑hr or 0/2‑hr algorithm with HEART score. Low HEART (0–3) + two negative troponins → safe discharge with rapid follow‑up.\n",
      "  - Elevated troponin can occur in PE, myocarditis, pericarditis (myopericarditis). Context and echo matter.\n",
      "- Echo:\n",
      "  - Pericardial effusion/tamponade (RV diastolic collapse, IVC plethora). If tamponade physiology with hypotension—urgent pericardiocentesis.\n",
      "  - RV dilation/strain suggests significant PE; may support lysis in shock if CTPA not immediately available.\n",
      "- Treatment specifics:\n",
      "  - Pericarditis: ibuprofen 600–800 mg TID or indomethacin; plus colchicine 0.5 mg BID (0.5 mg daily if <70 kg) for 3 months; PPI prophylaxis; restrict exercise. Admit if high‑risk features (fever >38°C, subacute course, large effusion, tamponade, anticoagulation, immunosuppression).\n",
      "  - Avoid NSAIDs if MI suspected; use acetaminophen for pain until ACS excluded.\n",
      "\n",
      "Dr. Alvarez: I’ll push back on avoiding D‑dimer in all low-risk cases—if the pretest probability is not clearly low, a missed PE is catastrophic. But I agree: if PERC negative with clean exam and normal vitals, no D‑dimer is evidence-based.\n",
      "\n",
      "Dr. Rahman: Agreed—but let’s be disciplined. PERC is only valid if the clinician’s gestalt is low pretest probability. Otherwise, use Wells or YEARS. Overusing D‑dimer in moderate/high risk just creates imaging delays.\n",
      "\n",
      "Dr. Desai: And please, ECG first always. If you see classic pericarditis, prioritize echo and anti-inflammatory therapy rather than rushing to CT unless PE features coexist.\n",
      "\n",
      "Dr. Alvarez: For pneumothorax, bedside US beats CXR especially in early or supine films. If unstable, I’ll needle decompress before imaging. Stable, small primary spontaneous pneumothorax can be observed with oxygen; larger or symptomatic → pigtail/chest tube. For secondary (COPD), lower threshold for tube.\n",
      "\n",
      "Targeted questions to refine right now:\n",
      "- Do you have shortness of breath at rest or with minimal exertion? Any fainting?\n",
      "- Is the pain worse lying flat and better leaning forward? Any recent viral illness?\n",
      "- Any cough, fever, or purulent sputum? Chills, pleural friction rub?\n",
      "- Any unilateral leg swelling/pain, recent flight or surgery, OCPs/pregnancy?\n",
      "- Sudden onset after stretching/coughing, with one-sided decreased breath sounds?\n",
      "- Is the pain reproducible by pressing on the chest wall? Any shingles rash?\n",
      "- Age and kidney function? History of cancer, clotting disorders, autoimmune disease?\n",
      "\n",
      "Provisional, branch-based plan (until we have your answers):\n",
      "- If low-risk by history/exam, PERC negative, normal vitals, normal ECG, normal lung US/CXR:\n",
      "  - Diagnosis: likely viral pleurisy or musculoskeletal.\n",
      "  - Treatment: ibuprofen 600–800 mg TID (if no GI/renal risk) or acetaminophen; consider short course colchicine if recurrent pleurisy; return precautions for dyspnea, fever, syncope; clinic follow-up in 48–72 hours.\n",
      "- If PE suspected (moderate/high pretest or D‑dimer positive):\n",
      "  - Imaging: CTPA (or V/Q if pregnant/renal impairment). Lower-extremity Doppler if imaging delayed.\n",
      "  - If hemodynamically unstable and bedside echo shows RV strain, consider thrombolysis after excluding dissection; start anticoagulation if no contraindications (e.g., apixaban 10 mg BID x7 days then 5 mg BID; or IV heparin if high bleeding risk/need reversibility). In pregnancy, LMWH.\n",
      "- If pneumothorax suspected:\n",
      "  - Unstable: immediate needle decompression then chest tube.\n",
      "  - Stable: confirm with US/CXR; observe with oxygen for small PSP; pigtail/chest tube for larger or secondary.\n",
      "- If pericarditis/myopericarditis suspected:\n",
      "  - ECG, inflammatory markers, echo. Start NSAID + colchicine; avoid anticoagulation unless PE present; admit if high-risk.\n",
      "- If pneumonia suspected:\n",
      "  - CXR, consider US and basic labs; CURB‑65/PSI for disposition.\n",
      "  - Outpatient antibiotics vs admission per severity; ensure early follow-up and return precautions.\n",
      "\n",
      "Points of contention and consensus:\n",
      "- We all agree on ECG within 10 minutes and bedside ultrasound early.\n",
      "- We agree to use PERC/Wells/YEARS correctly to limit unnecessary CT while not missing PE.\n",
      "- Imaging choice in pregnancy/renal impairment: consensus on V/Q if CXR normal; otherwise tailored.\n",
      "- Cardiology and pulmonology agree: pericarditis deserves early echo and anti-inflammatory therapy; avoid NSAIDs until MI excluded.\n",
      "\n",
      "Next steps for you:\n",
      "- Please answer the targeted questions above and provide age, sex, vital signs (HR, BP, RR, SpO2, temp), and any recent travel/surgery/pregnancy status. That will immediately place you on one of the branches and we’ll finalize testing and treatment on the spot.\n",
      "\n",
      "Dr. Alvarez: My vote for the “best initial pathway” in the ED is: ECG + vitals + bedside US, then apply PERC/Wells/YEARS to decide D‑dimer/CT, while obtaining a CXR in most cases. It’s fast, safe, and minimizes misses.\n",
      "\n",
      "Dr. Rahman: I concur, with strict adherence to pretest probability tools to avoid over-imaging and with tailored imaging in pregnancy/renal disease.\n",
      "\n",
      "Dr. Desai: And build in the rapid troponin/HEART pathway and echo when pericarditis is suspected. That’s our consensus plan.\n",
      "\n",
      "Thank you!\n",
      "\n",
      "--------------------------------------------------\n",
      "\n",
      "Final treatment plan for a patient with sharp, pleuritic chest pain\n",
      "\n",
      "Primary differential (prioritized by risk)\n",
      "- Immediately life-threatening: pulmonary embolism (PE), pneumothorax (including tension), acute pericarditis with tamponade; consider acute coronary syndrome (ACS) and aortic dissection if features suggest.\n",
      "- Serious but non-immediate: community-acquired pneumonia, myocarditis.\n",
      "- Benign/common: viral pleurisy, musculoskeletal chest wall pain (costochondritis), herpes zoster (pre-eruption).\n",
      "\n",
      "Initial stabilization and triage\n",
      "- Place on monitor; obtain full vitals and pulse oximetry; establish IV access.\n",
      "- 12-lead ECG within 10 minutes.\n",
      "- Provide supplemental oxygen to keep SpO2 ≥94% and analgesia (acetaminophen first if ACS not excluded; NSAIDs after MI excluded).\n",
      "- Rapid focused bedside ultrasound (lung and cardiac) to assess for pneumothorax, pleural effusion/consolidation, pericardial effusion, and RV strain.\n",
      "- Pregnancy test in women of childbearing potential before ionizing radiation or teratogenic meds.\n",
      "\n",
      "Recommended diagnostic tests (with justification)\n",
      "- ECG and serial high-sensitivity troponin (0/1–2 hours) with HEART score:\n",
      "  - Justification: exclude ACS/myopericarditis; ECG patterns help identify pericarditis or PE-related RV strain.\n",
      "- Chest imaging:\n",
      "  - Bedside lung ultrasound first (fast, radiation-free) to detect pneumothorax, effusion, focal consolidation.\n",
      "  - Chest X-ray for pneumothorax, lobar pneumonia, effusion, or alternative diagnoses.\n",
      "- PE evaluation using validated pretest tools:\n",
      "  - If clinician gestalt is low and PERC is negative: no D-dimer or CT.\n",
      "  - Otherwise use Wells or YEARS to decide testing:\n",
      "    - D-dimer if low/intermediate risk (age-adjusted threshold if >50; YEARS 1000 ng/mL FEU if 0 criteria, 500 if ≥1).\n",
      "    - CT pulmonary angiography (CTPA) if D-dimer positive or high pretest probability.\n",
      "    - Alternatives: V/Q scan if pregnant or significant renal dysfunction/contrast allergy and chest X-ray normal; bilateral lower-extremity Doppler ultrasound if chest imaging delayed—treat PE if proximal DVT found.\n",
      "- Echocardiography:\n",
      "  - If pericarditis/tamponade suspected, elevated troponin without ischemic ECG, or PE with concern for RV strain.\n",
      "- Laboratory tests:\n",
      "  - CBC, CMP (assess renal function for contrast and NSAID safety), CRP/ESR if pericarditis suspected.\n",
      "  - Consider viral testing (influenza/COVID) if febrile/URI symptoms; blood cultures if sepsis suspected.\n",
      "- Pneumonia severity scoring (CURB-65 or PSI) to guide disposition.\n",
      "\n",
      "Initial treatment (branch-based, initiate in parallel with diagnostics as appropriate)\n",
      "- If PE confirmed or highly likely:\n",
      "  - Hemodynamically unstable or shock with suspected PE and RV strain: immediate systemic thrombolysis after excluding aortic dissection; initiate IV unfractionated heparin; ICU; consider catheter-directed therapy with specialty input.\n",
      "  - Hemodynamically stable: start anticoagulation unless contraindicated:\n",
      "    - Apixaban 10 mg BID x 7 days then 5 mg BID; or rivaroxaban 15 mg BID x 21 days then 20 mg daily.\n",
      "    - Use LMWH in pregnancy and in active cancer; consider IV heparin if high bleeding risk or procedures anticipated.\n",
      "  - Oxygen to maintain SpO2 ≥94%; analgesia; assess for provoking factors and bleeding risks.\n",
      "- If pneumothorax:\n",
      "  - Tension physiology or instability: immediate needle decompression followed by chest tube.\n",
      "  - Stable:\n",
      "    - Small primary spontaneous: observe with supplemental oxygen and repeat imaging.\n",
      "    - Large or symptomatic primary, or any secondary (e.g., COPD): pigtail/chest tube; admit; thoracic surgery consultation as needed.\n",
      "- If acute pericarditis (no MI):\n",
      "  - NSAID (e.g., ibuprofen 600–800 mg three times daily) plus colchicine 0.5 mg twice daily (0.5 mg daily if <70 kg) for 3 months; PPI for GI protection; restrict strenuous activity until symptom and CRP normalization.\n",
      "  - Admit if high-risk features (fever >38°C, subacute course, large effusion, tamponade, on anticoagulation, immunosuppression, trauma).\n",
      "  - Avoid anticoagulation unless coexisting PE.\n",
      "- If pneumonia:\n",
      "  - Outpatient, no major comorbidities: amoxicillin 1 g TID or doxycycline 100 mg BID; supportive care (fluids, antipyretics).\n",
      "  - Outpatient with comorbidities: amoxicillin-clavulanate 875/125 mg BID plus doxycycline or azithromycin; or monotherapy with a respiratory fluoroquinolone if alternatives unsuitable.\n",
      "  - Inpatient (per severity): ceftriaxone plus azithromycin (adjust per local resistance, allergy, MRSA/Pseudomonas risks).\n",
      "- If low-risk pleurisy or musculoskeletal pain (after life-threatening causes excluded):\n",
      "  - NSAIDs (e.g., ibuprofen 600–800 mg TID with food and PPI if GI risk) or acetaminophen; topical lidocaine patch; heat/ice; cough suppression if needed.\n",
      "  - Consider colchicine 0.5 mg BID for 1–2 weeks for recurrent pleurisy.\n",
      "  - Activity modification; return precautions.\n",
      "- If ACS is suggested by ECG/troponin or high HEART: treat per ACS protocol and withhold NSAIDs.\n",
      "\n",
      "Follow-up and ongoing management\n",
      "- If discharged with benign diagnosis: re-evaluate within 48–72 hours or earlier if symptoms worsen.\n",
      "- PE:\n",
      "  - Anticoagulation counseling (bleeding precautions, adherence); arrange follow-up in 48–72 hours and at 1–3 months to determine treatment duration (minimum 3 months for provoked PE; consider extended therapy for unprovoked/high-risk).\n",
      "  - Consider evaluation for provoking factors; reserve thrombophilia testing for selected cases after anticoagulation course and not during acute phase.\n",
      "- Pericarditis:\n",
      "  - Cardiology follow-up within 1 week; track symptoms and CRP; wean NSAID over weeks once pain and CRP normalize; maintain colchicine for full 3 months to lower recurrence risk.\n",
      "- Pneumothorax:\n",
      "  - Repeat imaging to confirm resolution; counsel on smoking cessation; avoid air travel until radiographic resolution and scuba diving until specialty clearance; consider pleurodesis for recurrent or persistent air leak.\n",
      "- Pneumonia:\n",
      "  - Clinical reassessment at 48–72 hours; earlier if worsening; consider follow-up chest X-ray at 6–8 weeks if older age, smokers, or persistent symptoms.\n",
      "\n",
      "Red flags and escalation\n",
      "- Immediate ED/ICU escalation if any of the following occur:\n",
      "  - Hemodynamic instability (SBP <90 mmHg or MAP <65), new syncope, or sustained tachycardia >120.\n",
      "  - SpO2 <90% on room air or increasing oxygen requirement.\n",
      "  - Signs of tension pneumothorax (severe dyspnea, unilateral decreased breath sounds, hypotension, distended neck veins).\n",
      "  - Signs of tamponade (hypotension, elevated JVP, muffled heart sounds) or large pericardial effusion on imaging.\n",
      "  - Massive hemoptysis, marked respiratory distress, or rapidly progressive dyspnea.\n",
      "  - Focal neurologic deficits, tearing chest/back pain with pulse deficits (consider aortic dissection).\n",
      "  - High fever with rigors, immunosuppression, pregnancy with worsening chest pain/dyspnea, or inability to control pain at home.\n",
      "\n",
      "This plan uses a structured, probability-based approach to minimize missed life-threatening disease while avoiding unnecessary testing, and provides clear diagnostic and treatment pathways tailored to the most likely etiologies of pleuritic chest pain.\n",
      "\n",
      "Final plan complete.\n",
      "\n",
      "--------------------------------------------------\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# Input\n",
    "symptom=input(\"Enter symptom\")\n",
    "max_doctors=3\n",
    "doctors=[]\n",
    "max_num_turns = 15\n",
    "topic = \"Treating the symptom\"\n",
    "thread = {\"configurable\": {\"thread_id\": \"5\"}}\n",
    "initial_state = {\n",
    "    \"messages\": [\n",
    "        {\"role\": \"user\", \"content\": symptom}\n",
    "    ],\n",
    "    \"symptom\": symptom,\n",
    "    \"max_doctors\": max_doctors,\n",
    "    \"doctors\": doctors,\n",
    "    \"context\": [],\n",
    "    \"max_num_turns\": max_num_turns,\n",
    "    \"debate\": topic,\n",
    "    \"sections\": []\n",
    "}\n",
    "\n",
    "final_plan = None\n",
    "final_state = None\n",
    "\n",
    "for event in final_graph.stream(initial_state, thread, stream_mode=\"values\"):\n",
    "    final_state = event\n",
    "\n",
    "\n",
    "print(final_state.keys())\n",
    "print(final_state['doctors'])\n",
    "for m in final_state['messages']:\n",
    "    print(m.content)\n",
    "    print(\"\\n\" + \"-\"*50 + \"\\n\")   # optional separator\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "b04715d2-a963-49eb-ba57-e1584a87fe84",
   "metadata": {},
   "outputs": [
    {
     "name": "stdin",
     "output_type": "stream",
     "text": [
      "Enter symptom I have had some pain in my knees whenever I bend it fully\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "dict_keys(['symptom', 'max_doctors', 'doctors', 'max_num_turns', 'context', 'debate', 'sections', 'messages'])\n",
      "[Doctor(name='Dr. Maya R. Desai', qualifications='MD, FAAOS', specialization='Orthopedic Surgeon (Knee & Sports Injuries)', experience=14, description='Attending orthopaedic surgeon at Regional Joint & Sports Institute. Focuses on knee arthroscopy, meniscal and ligamentous injuries, patellofemoral pain, and early osteoarthritis. Offers image-guided injections and personalized rehab pathways. Led a multicenter study on outcomes after meniscal preservation.'), Doctor(name='Dr. Samuel P. Nguyen', qualifications='MD, CAQSM, FACSM', specialization='Sports Medicine Physician', experience=12, description='Primary Care Sports Medicine specialist at Metro Sports Medicine & Performance Clinic. Expertise in nonoperative management of knee pain, diagnostic musculoskeletal ultrasound, tendinopathies, biomechanical assessment, and return-to-activity programs. Provides PRP and viscosupplementation when appropriate.'), Doctor(name='Dr. Elena García', qualifications='MD, FACP, FACR', specialization='Rheumatologist', experience=16, description='Consultant rheumatologist at City Rheumatology Center. Specializes in inflammatory and crystal arthropathies affecting the knee, including rheumatoid arthritis, psoriatic arthritis, gout, and bursitis. Utilizes MSK ultrasound for synovitis detection and joint aspiration; published on early knee osteoarthritis phenotyping.')]\n",
      "Dr. Miguel Alvarez (Emergency Medicine): I’m Dr. Miguel Alvarez, emergency physician. If the presenting symptom is sharp, pleuritic chest pain (worse with deep breath/cough), my priority is ruling out immediately life-threatening causes within minutes: pulmonary embolism (PE), pneumothorax, pericarditis with tamponade, and less likely but critical aortic dissection and acute coronary syndrome (ACS). My first moves in the ED:\n",
      "- Triage and monitoring: vitals, continuous pulse ox, 12‑lead ECG within 10 minutes, IV access.\n",
      "- Focused bedside lung and cardiac ultrasound: look for absent lung sliding/“barcode” sign (pneumothorax), pleural effusion, focal consolidation with dynamic air bronchograms (pneumonia), RV strain or pericardial effusion/tamponade physiology.\n",
      "- Immediate analgesia and oxygen if SpO2 < 94%.\n",
      "\n",
      "Questions for the patient:\n",
      "- Onset and character: sudden vs gradual? Worsened by inspiration, cough, or lying flat? Better leaning forward?\n",
      "- Dyspnea severity, syncope, hemoptysis, fever/cough/sputum, calf pain/swelling, recent immobilization/surgery/long flight, known cancer, prior DVT/PE.\n",
      "- Trauma (even minor), body habitus (tall/slender or COPD risk for pneumothorax), recent viral illness.\n",
      "- Risk factors: pregnancy, OCPs/HRT, smoking, cocaine.\n",
      "- Chest wall tenderness, dermatomal rash (zoster), autoimmune disease.\n",
      "- For ACS overlap: exertional chest pressure, radiation to arm/jaw, diaphoresis, N/V.\n",
      "\n",
      "Based on answers and vitals, I’ll apply:\n",
      "- PE: PERC (if pretest probability truly low); if not low, use Wells/YEARS to guide D‑dimer and imaging. Age‑adjust D‑dimer: age × 10 ng/mL (FEU) if >50. YEARS: if 0 items and D‑dimer <1000 FEU, PE excluded; if ≥1 item, threshold 500.\n",
      "- Pneumothorax: if unstable with absent breath sounds and hypotension/JVD, decompress immediately; otherwise confirm with lung US/CXR.\n",
      "- Pericarditis: pleuritic pain worse supine, better leaning forward; pericardial rub; ECG with diffuse ST elevations and PR depression. Echo for effusion.\n",
      "- ACS: even if pleuritic, I won’t ignore ischemia—serial high‑sensitivity troponins at 0/1–2 hours with HEART score.\n",
      "\n",
      "Dr. Aisha Rahman (Pulmonology): I’m Dr. Aisha Rahman, pulmonologist. My lens is that pleuritic pain is pulmonary until proven otherwise. Over-testing is a risk, but missing PE or pneumothorax is worse. I advocate a structured pretest pathway to avoid unnecessary CTPA:\n",
      "- If vitals normal, SpO2 ≥ 96%, no risk factors, PERC negative, and normal lung US/CXR: likely benign/viral pleurisy or costochondritis—no D‑dimer or CT needed. NSAIDs and follow‑up.\n",
      "- If PE is possible (Wells ≥ 2 or YEARS positive), get D‑dimer with appropriate thresholding; proceed to CTPA if positive. Special cases:\n",
      "  - Pregnancy: obtain CXR first; if normal, V/Q scan preferred; if abnormal CXR or V/Q unavailable, CTPA with pregnancy protocol shielding. Use clinical gestalt—don’t use D‑dimer late pregnancy.\n",
      "  - Renal dysfunction or severe contrast allergy: consider V/Q or lower‑extremity Doppler ultrasound; treat if proximal DVT found.\n",
      "- Imaging specifics:\n",
      "  - Lung US: pneumothorax—absence of lung sliding, lung point if present is pathognomonic; pneumonia—subpleural consolidation, B‑lines, dynamic air bronchograms; pleural effusion—anechoic dependent fluid.\n",
      "  - CXR: quick screen for pneumothorax (expiratory film not needed with US), lobar pneumonia, effusion, rib fractures.\n",
      "- If pneumonia suspected: obtain CXR and consider procalcitonin if equivocal; risk stratify with CURB‑65 or PSI for disposition. Treat per guideline (e.g., outpatient amoxicillin/clavulanate + doxycycline or a respiratory fluoroquinolone in select cases; inpatient ceftriaxone + azithromycin).\n",
      "- If isolated pleuritis (viral/autoimmune): NSAIDs (e.g., ibuprofen 600–800 mg TID with PPI), consider colchicine 0.5 mg BID for 1–2 weeks for recurrent pleurisy; check CRP/ESR. If recurrent/prolonged or with exudative effusion, evaluate for TB, malignancy, autoimmune disease.\n",
      "\n",
      "Dr. Priya Desai (Cardiology): I’m Dr. Priya Desai, cardiologist. Pleuritic pain is often non-ischemic, but I’m most concerned about pericarditis, myocarditis, PE‑related RV strain, and the rare ACS that presents atypically. My concrete steps:\n",
      "- ECG interpretation specifics:\n",
      "  - Acute pericarditis: diffuse concave ST elevation with PR depression; Spodick’s sign (downsloping TP segment). No reciprocal ST depression except aVR/V1.\n",
      "  - PE: sinus tachycardia; S1Q3T3, T‑wave inversions V1–V4, right axis, incomplete RBBB—suggestive of RV strain.\n",
      "  - ACS: localized ST changes, reciprocal depressions.\n",
      "- Biomarkers:\n",
      "  - High‑sensitivity troponin 0/1‑hr or 0/2‑hr algorithm with HEART score. Low HEART (0–3) + two negative troponins → safe discharge with rapid follow‑up.\n",
      "  - Elevated troponin can occur in PE, myocarditis, pericarditis (myopericarditis). Context and echo matter.\n",
      "- Echo:\n",
      "  - Pericardial effusion/tamponade (RV diastolic collapse, IVC plethora). If tamponade physiology with hypotension—urgent pericardiocentesis.\n",
      "  - RV dilation/strain suggests significant PE; may support lysis in shock if CTPA not immediately available.\n",
      "- Treatment specifics:\n",
      "  - Pericarditis: ibuprofen 600–800 mg TID or indomethacin; plus colchicine 0.5 mg BID (0.5 mg daily if <70 kg) for 3 months; PPI prophylaxis; restrict exercise. Admit if high‑risk features (fever >38°C, subacute course, large effusion, tamponade, anticoagulation, immunosuppression).\n",
      "  - Avoid NSAIDs if MI suspected; use acetaminophen for pain until ACS excluded.\n",
      "\n",
      "Dr. Alvarez: I’ll push back on avoiding D‑dimer in all low-risk cases—if the pretest probability is not clearly low, a missed PE is catastrophic. But I agree: if PERC negative with clean exam and normal vitals, no D‑dimer is evidence-based.\n",
      "\n",
      "Dr. Rahman: Agreed—but let’s be disciplined. PERC is only valid if the clinician’s gestalt is low pretest probability. Otherwise, use Wells or YEARS. Overusing D‑dimer in moderate/high risk just creates imaging delays.\n",
      "\n",
      "Dr. Desai: And please, ECG first always. If you see classic pericarditis, prioritize echo and anti-inflammatory therapy rather than rushing to CT unless PE features coexist.\n",
      "\n",
      "Dr. Alvarez: For pneumothorax, bedside US beats CXR especially in early or supine films. If unstable, I’ll needle decompress before imaging. Stable, small primary spontaneous pneumothorax can be observed with oxygen; larger or symptomatic → pigtail/chest tube. For secondary (COPD), lower threshold for tube.\n",
      "\n",
      "Targeted questions to refine right now:\n",
      "- Do you have shortness of breath at rest or with minimal exertion? Any fainting?\n",
      "- Is the pain worse lying flat and better leaning forward? Any recent viral illness?\n",
      "- Any cough, fever, or purulent sputum? Chills, pleural friction rub?\n",
      "- Any unilateral leg swelling/pain, recent flight or surgery, OCPs/pregnancy?\n",
      "- Sudden onset after stretching/coughing, with one-sided decreased breath sounds?\n",
      "- Is the pain reproducible by pressing on the chest wall? Any shingles rash?\n",
      "- Age and kidney function? History of cancer, clotting disorders, autoimmune disease?\n",
      "\n",
      "Provisional, branch-based plan (until we have your answers):\n",
      "- If low-risk by history/exam, PERC negative, normal vitals, normal ECG, normal lung US/CXR:\n",
      "  - Diagnosis: likely viral pleurisy or musculoskeletal.\n",
      "  - Treatment: ibuprofen 600–800 mg TID (if no GI/renal risk) or acetaminophen; consider short course colchicine if recurrent pleurisy; return precautions for dyspnea, fever, syncope; clinic follow-up in 48–72 hours.\n",
      "- If PE suspected (moderate/high pretest or D‑dimer positive):\n",
      "  - Imaging: CTPA (or V/Q if pregnant/renal impairment). Lower-extremity Doppler if imaging delayed.\n",
      "  - If hemodynamically unstable and bedside echo shows RV strain, consider thrombolysis after excluding dissection; start anticoagulation if no contraindications (e.g., apixaban 10 mg BID x7 days then 5 mg BID; or IV heparin if high bleeding risk/need reversibility). In pregnancy, LMWH.\n",
      "- If pneumothorax suspected:\n",
      "  - Unstable: immediate needle decompression then chest tube.\n",
      "  - Stable: confirm with US/CXR; observe with oxygen for small PSP; pigtail/chest tube for larger or secondary.\n",
      "- If pericarditis/myopericarditis suspected:\n",
      "  - ECG, inflammatory markers, echo. Start NSAID + colchicine; avoid anticoagulation unless PE present; admit if high-risk.\n",
      "- If pneumonia suspected:\n",
      "  - CXR, consider US and basic labs; CURB‑65/PSI for disposition.\n",
      "  - Outpatient antibiotics vs admission per severity; ensure early follow-up and return precautions.\n",
      "\n",
      "Points of contention and consensus:\n",
      "- We all agree on ECG within 10 minutes and bedside ultrasound early.\n",
      "- We agree to use PERC/Wells/YEARS correctly to limit unnecessary CT while not missing PE.\n",
      "- Imaging choice in pregnancy/renal impairment: consensus on V/Q if CXR normal; otherwise tailored.\n",
      "- Cardiology and pulmonology agree: pericarditis deserves early echo and anti-inflammatory therapy; avoid NSAIDs until MI excluded.\n",
      "\n",
      "Next steps for you:\n",
      "- Please answer the targeted questions above and provide age, sex, vital signs (HR, BP, RR, SpO2, temp), and any recent travel/surgery/pregnancy status. That will immediately place you on one of the branches and we’ll finalize testing and treatment on the spot.\n",
      "\n",
      "Dr. Alvarez: My vote for the “best initial pathway” in the ED is: ECG + vitals + bedside US, then apply PERC/Wells/YEARS to decide D‑dimer/CT, while obtaining a CXR in most cases. It’s fast, safe, and minimizes misses.\n",
      "\n",
      "Dr. Rahman: I concur, with strict adherence to pretest probability tools to avoid over-imaging and with tailored imaging in pregnancy/renal disease.\n",
      "\n",
      "Dr. Desai: And build in the rapid troponin/HEART pathway and echo when pericarditis is suspected. That’s our consensus plan.\n",
      "\n",
      "Thank you!\n",
      "\n",
      "--------------------------------------------------\n",
      "\n",
      "Final treatment plan for a patient with sharp, pleuritic chest pain\n",
      "\n",
      "Primary differential (prioritized by risk)\n",
      "- Immediately life-threatening: pulmonary embolism (PE), pneumothorax (including tension), acute pericarditis with tamponade; consider acute coronary syndrome (ACS) and aortic dissection if features suggest.\n",
      "- Serious but non-immediate: community-acquired pneumonia, myocarditis.\n",
      "- Benign/common: viral pleurisy, musculoskeletal chest wall pain (costochondritis), herpes zoster (pre-eruption).\n",
      "\n",
      "Initial stabilization and triage\n",
      "- Place on monitor; obtain full vitals and pulse oximetry; establish IV access.\n",
      "- 12-lead ECG within 10 minutes.\n",
      "- Provide supplemental oxygen to keep SpO2 ≥94% and analgesia (acetaminophen first if ACS not excluded; NSAIDs after MI excluded).\n",
      "- Rapid focused bedside ultrasound (lung and cardiac) to assess for pneumothorax, pleural effusion/consolidation, pericardial effusion, and RV strain.\n",
      "- Pregnancy test in women of childbearing potential before ionizing radiation or teratogenic meds.\n",
      "\n",
      "Recommended diagnostic tests (with justification)\n",
      "- ECG and serial high-sensitivity troponin (0/1–2 hours) with HEART score:\n",
      "  - Justification: exclude ACS/myopericarditis; ECG patterns help identify pericarditis or PE-related RV strain.\n",
      "- Chest imaging:\n",
      "  - Bedside lung ultrasound first (fast, radiation-free) to detect pneumothorax, effusion, focal consolidation.\n",
      "  - Chest X-ray for pneumothorax, lobar pneumonia, effusion, or alternative diagnoses.\n",
      "- PE evaluation using validated pretest tools:\n",
      "  - If clinician gestalt is low and PERC is negative: no D-dimer or CT.\n",
      "  - Otherwise use Wells or YEARS to decide testing:\n",
      "    - D-dimer if low/intermediate risk (age-adjusted threshold if >50; YEARS 1000 ng/mL FEU if 0 criteria, 500 if ≥1).\n",
      "    - CT pulmonary angiography (CTPA) if D-dimer positive or high pretest probability.\n",
      "    - Alternatives: V/Q scan if pregnant or significant renal dysfunction/contrast allergy and chest X-ray normal; bilateral lower-extremity Doppler ultrasound if chest imaging delayed—treat PE if proximal DVT found.\n",
      "- Echocardiography:\n",
      "  - If pericarditis/tamponade suspected, elevated troponin without ischemic ECG, or PE with concern for RV strain.\n",
      "- Laboratory tests:\n",
      "  - CBC, CMP (assess renal function for contrast and NSAID safety), CRP/ESR if pericarditis suspected.\n",
      "  - Consider viral testing (influenza/COVID) if febrile/URI symptoms; blood cultures if sepsis suspected.\n",
      "- Pneumonia severity scoring (CURB-65 or PSI) to guide disposition.\n",
      "\n",
      "Initial treatment (branch-based, initiate in parallel with diagnostics as appropriate)\n",
      "- If PE confirmed or highly likely:\n",
      "  - Hemodynamically unstable or shock with suspected PE and RV strain: immediate systemic thrombolysis after excluding aortic dissection; initiate IV unfractionated heparin; ICU; consider catheter-directed therapy with specialty input.\n",
      "  - Hemodynamically stable: start anticoagulation unless contraindicated:\n",
      "    - Apixaban 10 mg BID x 7 days then 5 mg BID; or rivaroxaban 15 mg BID x 21 days then 20 mg daily.\n",
      "    - Use LMWH in pregnancy and in active cancer; consider IV heparin if high bleeding risk or procedures anticipated.\n",
      "  - Oxygen to maintain SpO2 ≥94%; analgesia; assess for provoking factors and bleeding risks.\n",
      "- If pneumothorax:\n",
      "  - Tension physiology or instability: immediate needle decompression followed by chest tube.\n",
      "  - Stable:\n",
      "    - Small primary spontaneous: observe with supplemental oxygen and repeat imaging.\n",
      "    - Large or symptomatic primary, or any secondary (e.g., COPD): pigtail/chest tube; admit; thoracic surgery consultation as needed.\n",
      "- If acute pericarditis (no MI):\n",
      "  - NSAID (e.g., ibuprofen 600–800 mg three times daily) plus colchicine 0.5 mg twice daily (0.5 mg daily if <70 kg) for 3 months; PPI for GI protection; restrict strenuous activity until symptom and CRP normalization.\n",
      "  - Admit if high-risk features (fever >38°C, subacute course, large effusion, tamponade, on anticoagulation, immunosuppression, trauma).\n",
      "  - Avoid anticoagulation unless coexisting PE.\n",
      "- If pneumonia:\n",
      "  - Outpatient, no major comorbidities: amoxicillin 1 g TID or doxycycline 100 mg BID; supportive care (fluids, antipyretics).\n",
      "  - Outpatient with comorbidities: amoxicillin-clavulanate 875/125 mg BID plus doxycycline or azithromycin; or monotherapy with a respiratory fluoroquinolone if alternatives unsuitable.\n",
      "  - Inpatient (per severity): ceftriaxone plus azithromycin (adjust per local resistance, allergy, MRSA/Pseudomonas risks).\n",
      "- If low-risk pleurisy or musculoskeletal pain (after life-threatening causes excluded):\n",
      "  - NSAIDs (e.g., ibuprofen 600–800 mg TID with food and PPI if GI risk) or acetaminophen; topical lidocaine patch; heat/ice; cough suppression if needed.\n",
      "  - Consider colchicine 0.5 mg BID for 1–2 weeks for recurrent pleurisy.\n",
      "  - Activity modification; return precautions.\n",
      "- If ACS is suggested by ECG/troponin or high HEART: treat per ACS protocol and withhold NSAIDs.\n",
      "\n",
      "Follow-up and ongoing management\n",
      "- If discharged with benign diagnosis: re-evaluate within 48–72 hours or earlier if symptoms worsen.\n",
      "- PE:\n",
      "  - Anticoagulation counseling (bleeding precautions, adherence); arrange follow-up in 48–72 hours and at 1–3 months to determine treatment duration (minimum 3 months for provoked PE; consider extended therapy for unprovoked/high-risk).\n",
      "  - Consider evaluation for provoking factors; reserve thrombophilia testing for selected cases after anticoagulation course and not during acute phase.\n",
      "- Pericarditis:\n",
      "  - Cardiology follow-up within 1 week; track symptoms and CRP; wean NSAID over weeks once pain and CRP normalize; maintain colchicine for full 3 months to lower recurrence risk.\n",
      "- Pneumothorax:\n",
      "  - Repeat imaging to confirm resolution; counsel on smoking cessation; avoid air travel until radiographic resolution and scuba diving until specialty clearance; consider pleurodesis for recurrent or persistent air leak.\n",
      "- Pneumonia:\n",
      "  - Clinical reassessment at 48–72 hours; earlier if worsening; consider follow-up chest X-ray at 6–8 weeks if older age, smokers, or persistent symptoms.\n",
      "\n",
      "Red flags and escalation\n",
      "- Immediate ED/ICU escalation if any of the following occur:\n",
      "  - Hemodynamic instability (SBP <90 mmHg or MAP <65), new syncope, or sustained tachycardia >120.\n",
      "  - SpO2 <90% on room air or increasing oxygen requirement.\n",
      "  - Signs of tension pneumothorax (severe dyspnea, unilateral decreased breath sounds, hypotension, distended neck veins).\n",
      "  - Signs of tamponade (hypotension, elevated JVP, muffled heart sounds) or large pericardial effusion on imaging.\n",
      "  - Massive hemoptysis, marked respiratory distress, or rapidly progressive dyspnea.\n",
      "  - Focal neurologic deficits, tearing chest/back pain with pulse deficits (consider aortic dissection).\n",
      "  - High fever with rigors, immunosuppression, pregnancy with worsening chest pain/dyspnea, or inability to control pain at home.\n",
      "\n",
      "This plan uses a structured, probability-based approach to minimize missed life-threatening disease while avoiding unnecessary testing, and provides clear diagnostic and treatment pathways tailored to the most likely etiologies of pleuritic chest pain.\n",
      "\n",
      "Final plan complete.\n",
      "\n",
      "--------------------------------------------------\n",
      "\n",
      "Dr. Miguel Alvarez (Emergency Medicine): I’m Dr. Miguel Alvarez. With sharp pain that’s worse with a deep breath or cough, my immediate job is to rule out the killers in minutes: pulmonary embolism (PE), pneumothorax (especially tension), pericardial tamponade, plus rare ACS or aortic dissection. In the ED I’d:\n",
      "- Put you on a monitor, check vitals and pulse ox, get a 12‑lead ECG within 10 minutes, establish IV access.\n",
      "- Do focused bedside ultrasound: lungs (look for absent lung sliding/barcode sign; lung point for pneumothorax; effusion; focal consolidation with dynamic air bronchograms) and heart (pericardial effusion, RV dilation/strain).\n",
      "- Give oxygen if SpO2 <94% and analgesia (acetaminophen initially until MI excluded).\n",
      "\n",
      "Key questions for you right now:\n",
      "- Onset: sudden “knife-like” vs gradual ache? Any fainting or near-syncope?\n",
      "- Pleuritic features: worse on deep breath/cough? Worse lying flat, better leaning forward (pericarditis)?\n",
      "- PE clues: leg swelling/pain, hemoptysis, recent immobilization/surgery/long travel, active cancer, pregnancy or estrogen, prior DVT/PE?\n",
      "- Pneumothorax clues: sudden pain after coughing/stretching, one-sided decreased breath sounds, tall/slim body habitus, COPD/asthma?\n",
      "- Infection: fever, rigors, productive cough, recent viral illness?\n",
      "- Chest wall: pain reproducible to touch? Any shingles rash?\n",
      "- Age/sex, vitals (HR, BP, RR, SpO2, temp), kidney function, allergies to contrast.\n",
      "\n",
      "Dr. Priya Desai (Cardiology): I’m Dr. Priya Desai. Pleuritic doesn’t automatically mean non-cardiac. I want to quickly sort out pericarditis/myopericarditis, PE‑related RV strain, and atypical ischemia.\n",
      "- ECG specifics I’ll look for:\n",
      "  - Pericarditis: diffuse concave ST elevation with PR depression, Spodick’s sign; no reciprocal depression except aVR/V1.\n",
      "  - PE: sinus tachycardia, S1Q3T3, T-wave inversions V1–V4, right axis, incomplete RBBB.\n",
      "  - ACS: localized ST changes with reciprocal depression.\n",
      "- Biomarkers:\n",
      "  - High‑sensitivity troponins at 0/1–2 hours with HEART score for risk. Elevated troponin can be PE/myocarditis/pericarditis—echo clarifies.\n",
      "- Echo:\n",
      "  - Detect effusion/tamponade (RV diastolic collapse, plethoric IVC), or RV strain from PE. If tamponade with hypotension: urgent pericardiocentesis.\n",
      "- Treatment stance:\n",
      "  - If ECG screams pericarditis and MI is excluded: NSAID (ibuprofen 600–800 mg TID) + colchicine 0.5 mg BID (0.5 mg daily if <70 kg) for 3 months; PPI; exercise restriction. Admit if fever >38°C, large effusion, anticoagulated, immunosuppressed, or tamponade features.\n",
      "  - Avoid NSAIDs until MI is excluded.\n",
      "\n",
      "Dr. Aisha Rahman (Pulmonology): I’m Dr. Aisha Rahman. Pleuritic pain is most often pulmonary. My aim is to not miss PE or pneumothorax while avoiding unnecessary CT scans.\n",
      "- Probability first:\n",
      "  - If gestalt is low and PERC negative, no D‑dimer/CT is needed. PERC items (all must be negative): age <50, HR <100, SpO2 ≥95%, no hemoptysis, no estrogen use, no prior DVT/PE, no unilateral leg swelling, no recent surgery/trauma with hospitalization. Note: pregnancy itself raises baseline risk—be cautious using PERC.\n",
      "  - Otherwise use Wells (≤4 “PE unlikely;” >4 “PE likely”) or YEARS (items: hemoptysis, DVT signs, “PE most likely”). With YEARS 0 criteria, D‑dimer threshold 1000 ng/mL FEU; if any criteria present, threshold 500.\n",
      "  - Age-adjust D‑dimer if >50: age × 10 ng/mL FEU.\n",
      "- Imaging choices:\n",
      "  - CTPA if D‑dimer positive or high pretest. If pregnant with normal CXR, do V/Q; if CXR abnormal or V/Q unavailable, use pregnancy‑protocol CTPA. With renal insufficiency or severe contrast allergy: V/Q or bilateral leg Dopplers—treat if DVT found.\n",
      "- Other pulmonary targets:\n",
      "  - Pneumothorax: lung US beats supine CXR (seashore vs barcode; lung point pathognomonic). Small primary pneumothorax: observe with O2; large/symptomatic or any secondary (COPD) → pigtail/chest tube.\n",
      "  - Pneumonia: CXR or lung US; risk‑stratify with CURB‑65/PSI. Outpatient: amoxicillin 1 g TID or doxycycline 100 mg BID; with comorbidities add amox‑clav or consider respiratory FQ if no better option. Inpatient: ceftriaxone + azithromycin.\n",
      "\n",
      "Dr. Alvarez: Quick pushback on PERC—absolutely only if my gestalt is truly low. If vitals are off, leg swelling, or concerning story, I’m not PERC‑ing; I’m using Wells/YEARS and moving to D‑dimer or straight to CTPA if high risk.\n",
      "\n",
      "Dr. Rahman: Agreed. Overusing D‑dimer in high-risk delays care and raises false positives. Underusing it in low-risk causes CT overuse. Discipline matters.\n",
      "\n",
      "Dr. Desai: And ECG first. If classic pericarditis pattern shows, I’ll prioritize echo and anti‑inflammatories unless PE features coexist. If troponin’s up without ischemic ECG, think myopericarditis—no anticoagulation unless we have a PE.\n",
      "\n",
      "How we’ll proceed in parallel (consensus pathway):\n",
      "1) Within 10 minutes: vitals, ECG, initial troponin, bedside lung + cardiac ultrasound.\n",
      "2) Apply PE probability correctly:\n",
      "   - If low gestalt and PERC negative: no D‑dimer/CT. Focus on pneumonia/pleurisy/costochondritis.\n",
      "   - Otherwise: Wells or YEARS → D‑dimer with appropriate thresholds; CTPA if positive or high risk.\n",
      "3) Tailor imaging:\n",
      "   - Pregnancy: CXR first; V/Q preferred if CXR normal.\n",
      "   - Renal impairment/contrast allergy: V/Q or bilateral leg Dopplers; treat if proximal DVT.\n",
      "4) Treat based on branch:\n",
      "   - PE: anticoagulate if stable (apixaban 10 mg BID ×7 days then 5 mg BID; or rivaroxaban 15 mg BID ×21 days then 20 mg daily; LMWH in pregnancy/cancer; IV heparin if high bleed risk/procedures). If shock with RV strain: systemic thrombolysis after excluding aortic dissection; consider catheter‑directed therapy.\n",
      "   - Pneumothorax: unstable → immediate decompression then tube. Stable small PSP → observe + O2; large/secondary → pigtail/chest tube.\n",
      "   - Pericarditis: NSAID + colchicine as above, PPI, activity restriction; admit if high‑risk. If tamponade physiology: urgent pericardiocentesis.\n",
      "   - Pneumonia: guideline antibiotics as above; severity‑based disposition.\n",
      "   - Low‑risk pleurisy/costochondritis (after ruling out dangerous causes): NSAIDs (e.g., ibuprofen 600–800 mg TID with food; or acetaminophen), topical lidocaine patch, heat/ice; brief colchicine if recurrent pleurisy; return precautions.\n",
      "   - Atypical ACS: manage per ACS pathway; avoid NSAIDs.\n",
      "\n",
      "Points we may debate and why our plan addresses them:\n",
      "- “Chest wall tenderness rules out PE.” It doesn’t. It lowers probability but PE can still coexist; hence we still run PERC/Wells appropriately. (Alvarez/Rahman)\n",
      "- “Troponin bump means MI.” Not necessarily—PE and myopericarditis cause troponin elevation; ECG/echo context is key. (Desai)\n",
      "- “Always CT for pleuritic pain.” No—use validated tools to avoid radiation/contrast when not needed. (Rahman)\n",
      "\n",
      "To tailor this to you, please tell us:\n",
      "- Age, sex, pregnancy status; current meds (including estrogen), allergies.\n",
      "- Exact pain description, onset timing, triggers (breath/cough/position), radiation, associated dyspnea/syncope/hemoptysis/fever/cough/leg swelling.\n",
      "- Any recent surgery, immobilization, trauma, flight (>4 hours), cancer history.\n",
      "- Vitals now: HR, BP, RR, SpO2, temperature.\n",
      "- Past lung/heart disease (asthma/COPD, prior pneumothorax, prior DVT/PE, coronary disease), kidney function if known.\n",
      "\n",
      "Once we have that, we’ll immediately place you on the right branch (PERC/Wells/YEARS; echo focus vs CT/VQ) and finalize tests and treatment on the spot.\n",
      "\n",
      "Dr. Alvarez: My vote for “best initial ED pathway” is ECG + vitals + bedside ultrasound, then validated PE tools to decide D‑dimer/CT, with a chest X‑ray in most cases—fast and safe.\n",
      "\n",
      "Dr. Rahman: And be strict with PERC/Wells/YEARS and imaging selection (V/Q in pregnancy or renal issues) to minimize harm without missing PE/pneumothorax/pneumonia.\n",
      "\n",
      "Dr. Desai: Add the rapid hs‑troponin/HEART pathway, early echo when pericarditis suspected, and avoid NSAIDs until MI is excluded. That’s our consensus.\n",
      "\n",
      "We’re ready to proceed once you provide the details above. Thank you!\n",
      "\n",
      "--------------------------------------------------\n",
      "\n",
      "Final medical treatment plan for sharp, pleuritic chest pain\n",
      "\n",
      "Primary diagnosis and prioritized differential\n",
      "- Immediately life-threatening (must be ruled out first): pulmonary embolism (PE), pneumothorax (including tension), acute pericarditis with tamponade. Consider acute coronary syndrome (ACS) and aortic dissection if features suggest.\n",
      "- Serious but typically non-immediate: community-acquired pneumonia, myocarditis.\n",
      "- Common/benign once above excluded: viral pleurisy, costochondritis, herpes zoster (pre-eruptive).\n",
      "\n",
      "Stabilization and triage\n",
      "- Continuous monitoring; obtain full vitals and pulse oximetry; establish IV access.\n",
      "- Oxygen to maintain SpO2 ≥94% if hypoxemic.\n",
      "- Early analgesia: acetaminophen initially until MI excluded; NSAIDs after ACS is ruled out.\n",
      "- Pregnancy test in women of childbearing potential prior to imaging or medications with fetal risk.\n",
      "\n",
      "Recommended diagnostic tests and pathway (with justification)\n",
      "1) Core tests for all:\n",
      "   - 12-lead ECG within 10 minutes: identifies pericarditis/myocarditis, ACS, or PE-related right heart strain.\n",
      "   - High-sensitivity troponin at 0 and 1–2 hours with HEART score: risk-stratifies ACS; troponin can be elevated in PE/myocarditis—interpret with ECG/echo.\n",
      "   - Point-of-care ultrasound (POCUS):\n",
      "     - Lung US: rapid detection of pneumothorax (absent lung sliding/barcode sign, lung point), pleural effusion, or focal consolidation.\n",
      "     - Focused cardiac US: pericardial effusion/tamponade, RV dilation/strain.\n",
      "   - Chest X-ray: identifies pneumothorax, lobar pneumonia, effusion, fractures; helps select V/Q vs CTPA.\n",
      "\n",
      "2) Pulmonary embolism workup (probability-based to avoid misses and over-imaging):\n",
      "   - If clinical gestalt is low AND PERC negative: PE excluded; no D-dimer/CT.\n",
      "   - Otherwise use Wells or YEARS to guide testing:\n",
      "     - Low/intermediate risk: D-dimer with appropriate thresholds.\n",
      "       - Age-adjusted D-dimer if >50 years: age × 10 ng/mL FEU.\n",
      "       - YEARS: if 0 criteria, threshold 1000 ng/mL FEU; if ≥1, threshold 500.\n",
      "       - Positive D-dimer → CT pulmonary angiography (CTPA).\n",
      "     - High pretest probability: proceed directly to CTPA.\n",
      "   - If CTPA contraindicated/unavailable: ventilation–perfusion (V/Q) scan if CXR normal; in pregnancy prefer V/Q if CXR normal, otherwise pregnancy-protocol CTPA. With significant renal dysfunction/contrast allergy, choose V/Q or bilateral lower-extremity Doppler ultrasound; treat if proximal DVT is found.\n",
      "\n",
      "3) Echocardiography:\n",
      "   - Obtain if ECG suggests pericarditis/myocarditis, if troponin elevated without ischemic pattern, if pericardial tamponade suspected, or if PE with concern for RV strain.\n",
      "\n",
      "4) Laboratory tests:\n",
      "   - CBC, CMP (renal function for contrast and NSAID safety), CRP/ESR (pericarditis activity).\n",
      "   - Consider viral testing (COVID/Influenza) if febrile/URI symptoms; blood cultures if sepsis suspected.\n",
      "\n",
      "5) Pneumonia assessment:\n",
      "   - Use CXR or lung US to confirm; apply CURB-65 or PSI for disposition.\n",
      "\n",
      "Initial treatment (initiate in parallel with diagnostics when indicated)\n",
      "- Pulmonary embolism:\n",
      "  - Hemodynamically unstable/suspected massive PE with RV strain: immediate IV unfractionated heparin and consider systemic thrombolysis after excluding aortic dissection; ICU care; consider catheter-directed therapy with specialty input.\n",
      "  - Hemodynamically stable: start anticoagulation unless contraindicated:\n",
      "    - Apixaban 10 mg twice daily for 7 days, then 5 mg twice daily; or rivaroxaban 15 mg twice daily for 21 days, then 20 mg daily.\n",
      "    - Low-molecular-weight heparin (LMWH) in pregnancy and in active cancer; IV heparin if high bleeding risk or procedures expected.\n",
      "  - Analgesia and oxygen as needed; evaluate for provoking factors.\n",
      "\n",
      "- Pneumothorax:\n",
      "  - Tension physiology or instability: immediate needle decompression, then chest tube thoracostomy.\n",
      "  - Stable:\n",
      "    - Small primary spontaneous: observe with supplemental oxygen and repeat imaging.\n",
      "    - Large or symptomatic primary, or any secondary (e.g., COPD): pigtail catheter/chest tube and admission; thoracic surgery consult as needed.\n",
      "\n",
      "- Acute pericarditis (after MI excluded):\n",
      "  - NSAID: ibuprofen 600–800 mg three times daily with PPI for GI protection.\n",
      "  - Colchicine: 0.6 mg twice daily (0.6 mg once daily if <70 kg or intolerance) for 3 months.\n",
      "  - Activity restriction until symptom and CRP normalization.\n",
      "  - Admit if high-risk features: fever >38°C, subacute course, large effusion, tamponade, anticoagulation, immunosuppression, or trauma.\n",
      "  - If tamponade physiology: urgent pericardiocentesis.\n",
      "\n",
      "- Community-acquired pneumonia:\n",
      "  - Outpatient, no major comorbidities: amoxicillin 1 g three times daily or doxycycline 100 mg twice daily.\n",
      "  - Outpatient with comorbidities: amoxicillin-clavulanate 875/125 mg twice daily plus doxycycline or azithromycin; or respiratory fluoroquinolone if alternatives unsuitable.\n",
      "  - Inpatient (per severity): ceftriaxone plus azithromycin (modify for allergies/resistance risks).\n",
      "\n",
      "- Low-risk pleurisy or costochondritis (after exclusion of dangerous causes):\n",
      "  - NSAIDs (e.g., ibuprofen as above) or acetaminophen; topical lidocaine patches; heat/ice; cough suppression if needed.\n",
      "  - Consider short course colchicine (0.6 mg once to twice daily for 1–2 weeks) for recurrent pleurisy.\n",
      "\n",
      "- ACS suspected by ECG/troponin or high HEART:\n",
      "  - Manage per ACS protocol (antiplatelets, anticoagulation, nitrates, statin, beta-blocker as appropriate) and avoid NSAIDs until MI excluded.\n",
      "\n",
      "Follow-up and disposition\n",
      "- Safe discharge criteria: normal/near-normal vitals, oxygenation stable on room air, life-threatening causes excluded or treated, pain controlled, reliable follow-up.\n",
      "- Reassessment:\n",
      "  - Benign diagnosis: clinic/telehealth follow-up in 48–72 hours or sooner if worsening.\n",
      "  - PE: structured follow-up in 48–72 hours for medication tolerance and bleeding assessment, then at 1–3 months to determine duration (minimum 3 months for provoked; consider extended therapy if unprovoked/high risk). Provide bleeding precautions and adherence counseling.\n",
      "  - Pericarditis: cardiology follow-up within 1 week; taper NSAID over weeks once asymptomatic and CRP normalized; complete full 3-month colchicine course to reduce recurrence.\n",
      "  - Pneumothorax: repeat imaging to confirm resolution; counsel to avoid air travel until radiographic resolution; no scuba diving until specialist clearance; smoking cessation.\n",
      "  - Pneumonia: clinical check in 48–72 hours; consider repeat CXR at 6–8 weeks in older patients, smokers, or if persistent symptoms.\n",
      "\n",
      "Red flags requiring immediate escalation/ED return\n",
      "- Hemodynamic instability (SBP <90 mmHg or MAP <65), new syncope, or sustained tachycardia >120 bpm.\n",
      "- SpO2 <90% on room air or increasing oxygen requirement.\n",
      "- Signs of tension pneumothorax (severe dyspnea, unilateral absent breath sounds, hypotension, distended neck veins).\n",
      "- Signs of cardiac tamponade (hypotension, elevated JVP, muffled heart sounds) or large pericardial effusion on imaging.\n",
      "- Massive hemoptysis, rapidly worsening dyspnea, or severe pleuritic pain unresponsive to analgesia.\n",
      "- High fever with rigors, immunosuppression, pregnancy with worsening dyspnea/chest pain.\n",
      "- Tearing chest/back pain with pulse deficits or neurologic symptoms (concern for aortic dissection).\n",
      "\n",
      "Notes and cautions\n",
      "- Chest wall tenderness does not exclude PE; use validated decision tools rather than single findings.\n",
      "- Use D-dimer judiciously: avoid in high pretest probability; age-adjust thresholds when appropriate.\n",
      "- Adjust medication dosing for renal/hepatic impairment; review drug interactions (e.g., colchicine, DOACs).\n",
      "\n",
      "Final plan complete.\n",
      "\n",
      "--------------------------------------------------\n",
      "\n"
     ]
    }
   ],
   "source": [
    "symptom=input(\"Enter symptom\")\n",
    "max_doctors=3\n",
    "doctors=[]\n",
    "max_num_turns = 15\n",
    "topic = \"Treating the symptom\"\n",
    "thread = {\"configurable\": {\"thread_id\": \"5\"}}\n",
    "initial_state = {\n",
    "    \"messages\": [\n",
    "        {\"role\": \"user\", \"content\": symptom}\n",
    "    ],\n",
    "    \"symptom\": symptom,\n",
    "    \"max_doctors\": max_doctors,\n",
    "    \"doctors\": doctors,\n",
    "    \"context\": [],\n",
    "    \"max_num_turns\": max_num_turns,\n",
    "    \"debate\": topic,\n",
    "    \"sections\": []\n",
    "}\n",
    "\n",
    "final_state = None\n",
    "\n",
    "for event in final_graph.stream(initial_state, thread, stream_mode=\"values\"):\n",
    "    final_state = event\n",
    "\n",
    "\n",
    "print(final_state.keys())\n",
    "print(final_state['doctors'])\n",
    "for m in final_state['messages']:\n",
    "    print(m.content)\n",
    "    print(\"\\n\" + \"-\"*50 + \"\\n\")   # optional separator\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "905d7878-ecf8-4586-ab3e-411221b8efaf",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "eb2df298-0ba0-4c15-8eba-20fa78f77bcf",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "8d516829-8a1d-44ef-946c-809fec8c925d",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
